Validity of Siriraj Stroke Score in Differentiating Cerebral Infarct and Haemorrhage in South Indians by Hibu Juli,
                                                                                          
  VALIDITY OF SIRIRAJ STROKE SCORE IN 
DIFFERENTIATING CEREBRAL INFARCT AND 
HAEMORRHAGE IN SOUTH INDIANS 
 
                      DISSERTATION SUBMITTED FOR THE 
                             AWARD OF THE DEGREE OF 
 
           M.D. GENERAL MEDICINE 
                         (BRANCH – I) 
                         APRIL – 2017 
                                    
 
                  DEPARMENT OF GENERAL MEDICINE 
                        MADURAI MEDICAL COLLEGE 
                                     MADURAI 625020 
                           THE TAMILNADU 
              DR.M.G.R. MEDICAL UNIVERSITY, 
                                  CHENNAI 
2 
 
 
 
CERTIFICATE FROM THE DEAN 
  
  
  
                  This is to certify that this dissertation entitled VALIDITY OF 
SIRIRAJ STROKE SCORE IN DIFFERENTIATING CEREBRAL 
INFARCT AND HAEMORRHAGE IN SOUTH INDIANS is the  
bonafide work of  Dr. HIBU JULI  in partial fulfillment of the university 
regulations of the Tamil Nadu Dr. M.G.R. Medical University, Chennai, for 
M.D General Medicine Branch I examination  to be held in April 2017. 
 
 
 
                                                                               Dr. M.R.VAIRAMUTHU RAJU MD. 
                                                                          The Dean, 
                                                                       Government Rajaji Hospital, 
                                                                           Madurai Medical College, 
                                                                           Madurai 
 
 
 
3 
 
 
 
CERTIFICATE FROM THE HEAD OF THE DEPARTMENT 
 
 
 
 
              This is to certify that this dissertation entitled “VALIDITY OF 
SIRIRAJ STROKE SCORE IN DIFFERENTIATING CEREBRAL 
INFARCT AND HAEMORRHAGE IN SOUTH INDIANS’’  is  the 
bonafide work  of  Dr. HIBU JULI  in partial fulfillment of the university 
regulations of the Tamil Nadu  Dr. M.G.R. Medical University, Chennai, for 
M.D General Medicine Branch I  examination to be held in April 2017. 
 
 
 
                                                                       DR.V.T.PREM KUMAR,M.D., 
                                         Professor and HOD, 
                                                                        Department Of General Medicine, 
                                                                 Government Rajaji Hospital, 
                                                              Madurai Medical College, 
                                  Madurai. 
 
 
4 
 
 
CERTIFICATE FROM THE GUIDE 
  
 
 
                     This is to certify that this dissertation entitled “VALIDITY OF 
SIRIRAJ STROKE SCORE IN DIFFERENTIATING CEREBRAL 
INFARCT AND HAEMORRHAGE IN SOUTH INDIANS’’ is the 
bonafide work of  Dr. HIBU JULI   in partial fulfillment of the university 
regulations of the Tamil Nadu  Dr. M.G.R. Medical University, Chennai, for 
M.D General Medicine Branch I examination to be held in April 2017. 
 
 
 
                                                                      Dr.J.SANGUMANI M.D, d.diab. 
                                                     Professor of Medicine, 
                                                                       Department Of General Medicine, 
                                                               Government Rajaji Hospital, 
                                                           Madurai Medical College, 
                              Madurai 
 
5 
 
 
 
DECLARATION 
 
 
      
             I Dr. HIBU JULI declare that, I carried out this work on “VALIDITY 
OF SIRIRAJ STROKE SCORE IN DIFFERENTIATING CEREBRAL 
INFARCT AND HAEMORRHAGE IN SOUTH INDIANS ’’ at the 
Department  of Medicine, Govt. Rajaji Hospital during the period MARCH 2016 
TO AUGUST  2016. I also declare that this bonafide work or a part of this work 
was not submitted by me or any others for any award, degree or diploma to any 
other University, Board either in India or abroad.   
           This dissertation is submitted to The Tamil Nadu Dr. M.G.R. Medical 
University, Chennai in partial fulfillment of the rules and regulations for the 
award of  M.D Degree General Medicine Branch- I; examination to be held 
in April 2017. 
  
 
  
Place:Madurai                                                                       
         DR. HIBU JULI 
Date    : 
 
 
6 
 
 
ACKNOWLEDGEMENTS 
 
 
  
  At the outset, I wish to thank our Dean Dr. M.R. 
VAIRAMUTHURAJU M.D., for permitting me to use the facilities of 
Madurai Medical College and Government Rajaji Hospital to conduct this 
study.  
            I would like to express my deep sense of gratitude and thanks to my beloved 
teacher and Head of the Department of Medicine Prof. Dr. 
V.T.PREMKUMAR M.D. He has always guided me, by example and valuable 
words of advice and has encouraged  innovative thinking and original 
research work done by post graduates.  
  I shall remain eternally grateful to my beloved teacher, my guide 
Dr.J.SANGUMANI M.D, d.diab who has given me his moral support and 
encouragement through the conduct of the study and also during my entire 
postgraduate course.  
           I also sincerely express my thanks to our Professors         
Dr.R.Balajinathan.M.D., Dr.M.Natarajan.M.D., Dr.G.Bagialakshmi, M.D., 
Dr.C.Dharmaraj.M.D., Dr.Ravindran M.D., Dr.Prabhakaran M.D., Dr.Peer 
Mohammed for their par excellence in clinical teaching and constant support. 
7 
 
 I am extremely grateful to Prof. Dr. SUMATHI, MD; Head of the 
department of RADIODIAGNOSIS for her constant support, guidance, 
cooperation and encouragement to complete this study. 
 
 I offer my heartfelt thanks to my Assistant Professors , Dr. R. 
SUNDARAM M.D. and Dr. K.S RAGHAVAN M.D, d.diab for their constant 
encouragement, timely help and critical suggestions throughout the study and 
also for making my stay in the unit both informative and pleasurable.  
 
  I express my thanks to Dr. PRAKASH, post graduate 
RADIODIAGNOSIS for his help and support in my dissertation work. 
 
 My patients, who form the most integral part of the work, were always 
kind and cooperative. I pray to God to give them courage and strength to 
endure their illness, hope all of them go into complete remission.  
 
 I thank my friends and family who have stood by me during my times of 
need. Their help and support have always been invaluable to me. And last but 
not the least I would like to thank the Lord Almighty for His grace and 
blessings without which nothing would have been possible. 
                                          
8 
 
 
CONTENTS 
 
 
SNO TITLE PAGE NO 
1 INTRODUCTION      1 -  9 
2 AIM AND OBJECTIVES        10 
3 REVIEW OF LITERATURE   11 – 78 
4 MATERIALS AND METHODS    79-88 
5 ANTIPICATED OUTCOME    89 – 95 
6 DISCUSSION    96 – 97 
7 CONCLUSION        98 
8 ANNEXURES  
 Bibliography  
 Proforma  
 Master Chart  
 Ethical Clearance letter 
 Anti Plagiarism Certificates 
 
 99 – 100 
101 – 102 
103 – 104 
      105 
106 – 107 
 
                                        
 
9 
 
 
INTRODUCTION 
  
 
 
                             Stroke is the second leading cause of death worldwide, causing 6.2 
million deaths in 2011. Stroke is a major health issue not only because it is a major 
cause of death but also because it leaves patients with several residual disabilities 
like physical dependence, dementia and depression. 
   Computed tomography (CT) scan is an accurate, safe, non-invasive procedure 
routinely used as an investigative tool for stroke to distinguish between infarction 
and haemorrhage. 
 Computed tomography scanning of brain is expensive in both the initial 
investment and maintenance. In developing countries like India, cost and availability 
constraints prohibit its widespread use especially in rural areas. 
 Clinical stroke scores were developed to overcome these limitations. 
Differential diagnosis between infarction and haemorrhage can be made on clinical 
grounds with aid of Siriraj Scoring System. CT scan is not readily available in semi-
urban and rural areas and the scoring systems will then come into play in 
differentiating the stroke subtype. This study is being done to determine the 
sensitivity, specificity of Siriraj score 
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AIMS AND OBJECTIVES 
 
1. To differentiate between cerebral infarct and intra cerebral hemorrhage on the 
basis of Siriraj Stroke Score. 
2. To find out the sensitivity, specificity and overall accuracy of the scoring 
system by comparing it with the CT scan findings. 
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REVIEW OF LITERATURE 
 Among all the neurologic diseases of adult life, the cerebrovascular ones 
clearly rank first in frequency and importance. At least 50 percent of the 
neurologic disorders in a general hospital are of this type. 
 Stroke is focal neurological deficit due to cerebral vascular cause which 
lasts more than 24 hours.  
 The term cerebrovascular disease designates any abnormality of the brain 
resulting from a pathologic process of the blood vessels. Pathologic process is 
given an inclusive meaning namely, occlusion of the lumen by embolus or 
thrombus, rupture of a vessel, an altered permeability of the vessel wall, or 
increased viscosity or other change in the quality of the blood flowing through 
the cerebral vessels. The vascular pathologic process may be considered not only 
in its grosser aspects of embolism, thrombosis, dissection, or rupture of a vessel 
but also in terms of the more basic or primary disorder, i.e., atherosclerosis, 
hypertensive arteriosclerotic change, arteritis, aneurysmal dilation, and 
developmental malformation. Equal importance attaches to the secondary 
parenchymal changes in the brain resulting from the vascular lesion. These are of 
two main types, ischemia, with or without infarction, and hemorrhage and unless 
one or the other occurs, the vascular lesion usually remains silent. The only 
exceptions to this statement are the local pressure effects of an aneurysm, 
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vascular headache (migraine, hypertension, temporal arteritis), multiple small 
vessel disease with progressive encephalopathy (as in malignant hypertension or 
cerebral arteritis), and increased intracranial pressure (as occurs in hypertensive 
encephalopathy and venous sinus thrombosis). Also, persistent acute hypotension 
may cause ischemic necrosis in regions of brain between the vascular territories 
of cortical vessels, even without vascular occlusion. 
Causes of cerebral abnormalities from alterations of arteries and veins 
1. Atherosclerotic thrombosis 
2. Transient ischemic attacks 
3. Embolism 
4. Hypertensive haemorrhage 
5. Ruptured or unruptured saccular aneurysm or AVM 
6. Arteritis 
a. Meningovascular syphilis, arteritis secondary to pyogenic and tuberculous 
meningitis, rare infective types (typhus, schistosomiasis, malaria, mucormycosis, 
etc.) 
b. Connective tissue diseases (polyarteritis nodosa, lupus erythematosus), 
necrotizing arteritis. Wegener arteritis, temporal arteritis, Takayasu disease, 
granulomatous or giant-cell arteritis of the aorta, and giant-cell granulomatous 
angiitis of cerebral arteries 
7. Cerebral thrombophlebitis: secondary to infection of ear, paranasal sinus, face, 
etc.; with meningitis and subdural empyema; debilitating states, postpartum, 
postoperative, cardiac failure, hematologic disease (polycythemia, sickle cell 
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disease), and of undetermined cause 
8. Hematologic disorders: anticoagulants and thrombolytics, clotting factor 
disorders, polycythemia, sickle cell disease, thrombotic thrombocytopenic 
purpura, thrombocytosis, intravascular lymphoma, etc. 
9. Trauma and dissection of carotid and basilar arteries 
10. Amyloid angiopathy 
11. Dissecting aortic aneurysm 
12. Complications of arteriography 
13. Neurologic migraine with persistent deficit 
14. With tentorial, foramen magnum, and subfalcial herniations 
15. Miscellaneous types: fibromuscular dysplasia, with local dissection of carotid, 
middle cerebral, or vertebrobasilar artery, x-irradiation, unexplained middle 
cerebral infarction in closed head injury, pressure of unruptured saccular 
aneurysm, complication of oral contraceptives 
16. Undetermined cause in children and young adults: moyamoya disease and others 
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Pathophysiology of Cerebral Ischemia and Ischemic Infarction 
 Cerebral infarction basically comprises two pathophysiologic processes, one, 
a loss in the supply of oxygen and glucose secondary to vascular occlusion, and the 
other, an array of changes in cellular metabolism consequent to the collapse of 
energy-producing processes, ultimately with disintegration of cell membranes. Of 
potential therapeutic importance are the observations that some of the cellular 
processes leading to neuronal death are not irrevocable and may be reversed by early 
intervention, either through restoration of blood flow, by prevention of the influx of 
calcium into cells, or by interdicting intermediary processes involved in cell death 
Vascular Factors 
 At the centre of an ischemic stroke is a zone of infarction. The necrotic tissue 
swells rapidly, mainly because of excessive intracellular and intercellular water 
content. Since anoxia also causes necrosis and swelling of cerebral tissue (although 
in a different distribution), oxygen lack must be a factor common to both infarction 
and anoxic encephalopathy. The effects of ischemia, whether functional and 
reversible or structural and irreversible, depend on its degree and duration. The 
margins of the infarct are hyperemic, being nourished by meningeal collaterals, and 
here there is only minimal or no parenchymal damage. 
 If the brain is observed at the time of arterial occlusion, the venous blood is 
first seen to darken, owing to an increase in reduced hemoglobin. The viscosity of 
the blood and resistance to flow both increase, and there is sludging of formed 
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elements within vessels. The tissue becomes pale. Arteries and arterioles become 
narrowed, especially in the pale areas. Upon re-establishing flow in the occluded 
artery, the sequence is reversed and there may be a slight hyperaemia. If the ischemia 
is prolonged, sludging and endothelial damage prevent normal reflow. 
 These flow factors have been studied in experimental animals by Heiss and by 
Siesjo and others and are reviewed in detail by Hossman. These investigators have 
determined the critical threshold of cerebral blood flow (CBF), measured by xenon 
clearance, below which functional impairment occurs. In several animal species, 
including macaque monkeys and gerbils, the critical level was 23 mL/100 g/min 
(normal is 55 mL); if, after short periods of time, CBF is restored to higher levels the 
impairment of function can be reversed. Reduction of CBF below 10 to 12 mL/100 
g/min causes infarction, almost regardless of its duration. The critical level of 
hypoperfusion that abolishes function and leads to tissue damage is therefore a CBF 
between 12 and 23 mL/100 g/min. At these levels of blood flow the EEG is slowed, 
and below this level it becomes isoelectric. In the region of marginal perfusion 
ischemic penumbra), the K level increases (efflux from injured depolarized cells) 
and ATP and creatine phosphate are depleted. These biochemical abnormalities are 
reversible if the circulation is restored to normal. Disturbance of calcium ion 
homeostasis and accumulation of free fatty acids interfere with full recovery. A CBF 
of 6 to 8 mL/100 g/min causes marked ATP depletion, increase in extracellular K, 
increase in intracellular Ca, and cellular acidosis, leading invariably to histologic 
signs of necrosis. These changes do not become apparent for several hours. Free 
fatty acids (appearing as phospholipases) are activated and destroy the phospholipids 
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of neuronal membranes. Prostaglandins, leukotrienes, and free radicals accumulate, 
and intracellular proteins and enzymes are denatured. Cells then swell, a process 
called cellular, or cytotoxic, edema. Similar abnormalities affect mitochondria, even 
before other cellular changes are evident. 
 Implicit in all discussions of ischemic stroke and its treatment is the existence 
of a penumbra zone that is marginally perfused and contains viable neurons. 
Presumably this zone exists at the margins of an infarction, which at its core has 
irrevocably damaged tissue that is destined to become necrotic. Using various 
methods, such a penumbra can be demonstrated in association with some infarctions 
but not all, and the degree of reversible tissue damage is difficult to determine. The 
neurons in the penumbra are considered to be stunned by moderate ischemia and 
subject to salvage if blood flow is restored in a certain period of time. As with all 
infarction, the duration of ischemia plays a role. Olsen and colleagues have been able 
to demonstrate hypoperfused penumbral zones but, interestingly, found that regions 
just adjacent to them are hyperperfused. Furthermore, these investigators and others 
have shown that elevating the systemic blood pressure or improving the rheologic 
flow properties of blood in small vessels by hemodilution improves flow in the 
penumbra; however, attempts to use these techniques in clinical work have met with 
mixed success. 
 The phenomenon of cerebrovascular autoregulation is appropriately 
introduced here. Over a range of mean blood pressures of approximately 50 to 150 
mm Hg, the small pial vessels are able to dilate and to constrict in order to maintain 
CBF in a relatively narrow range. This accommodation eventually fails at the 
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extremes of blood pressure, after which CBF follows systemic pressure passively, 
either falling precipitously or rising to levels that damage small vessel walls. The 
conditions in which the limits of autoregulation are exceeded are at the extremes of 
hypertensive encephalopathy at one end and circulatory failure at the other. 
Metabolic Factors 
 Interest has focused on the role of excitatory neurotransmitters, particularly 
glutamate and aspartate, which are formed from glycolytic intermediates of the 
Krebs cycle. It has been found that these neurotransmitters, released by ischemic 
cells, excite neurons and produce an intracellular influx of Na and Ca. These changes 
are said to be responsible for irreversible cell injury. This is presently a subject of 
active biochemical and clinical research. Some current attempts at therapy, for 
example, are directed at limiting the extent of infarction by blocking the glutamate 
receptor, particularly the NMDA (N-methyl-D-aspartate) channelone of several 
calcium channels that open under conditions of ischemia and set in motion a cascade 
of cellular events, eventuating in neuronal death. However, even complete blockade 
of the NMDA channels has so far not prevented cellular death, presumably because 
dysfunction of several other types of calcium channels continues. Novel strategies 
have been suggested to prevent calcium influx, but the drugs that block the various 
calcium channels seem to work only if given before the stroke, making this approach 
impractical in most situations. Additional biochemical events must be induced by 
ischemia, including the production of free radicals, which leads to peroxidation and 
disruption of the outer cell membrane. Clearly, the cascade of intracellular events 
that lead to neuronal death is likely to be more complex than is currently envisioned. 
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However, the extent of neural tissue dysfunction is not dictated solely by the 
activation of these mechanisms in neurons. It is now clear that highly toxic 
influences are exerted on oligodendroglial cells in white matter during ischemia. 
Moreover, the injury to both neurons and oligodendroglial cells is augmented in 
brain tissues by an inflammatory response to the initial injury, activating endothelial 
cells to express cell adhesion molecules that can attract additional inflammatory cells 
and upregulating levels of inflammatory proteases (e.g., metalloproteases) and 
cytokines (e.g. interleukins and chemokines). These events are summarized in the 
review by Lo and coworkers. 
 It is evident that these events are highly complex, invoking multiple parallel 
molecular phenomena. The salient feature of these molecular pathways is that they 
provide points for potential therapeutic interventions. As one example, it is clear that 
as ATP production fails and energy gradients are depleted, there is significant 
accumulation of lactic acid in cerebral tissue, and all the biochemical changes 
consequent to the cellular acidosis occur. These may also be of importance in 
determining the extent of cell damage (see reviews of Raichle and of Plum). Myers 
and Yamaguchi showed that monkeys infused with glucose before the induction of 
cardiac arrest suffered more brain damage than did either fasted or saline-infused 
animals. They suggested that the high cerebral glucose level under anaerobic 
conditions led to increased glycolysis during the ischemic episode and that the 
accumulated lactate was neurotoxic. On the basis of such observations, Plum has 
suggested that scrupulous control of the blood glucose might reduce the risk of 
cerebral infarction in diabetic and other stroke-prone patients and during conditions 
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of potential hyperglycemia. Clinical implementation of this idea is difficult and its 
advantages remain to be established. 
 Regarding anoxic damage of the brain, Ames and Nesbett have studied the 
rabbit retina in an immersion chamber in which O2 and various substrates could be 
altered directly rather than through the vasculature. They found that cells could 
withstand complete absence of O2 for 20 min. After 30 min of anoxia, there was 
irreversible damage, reflected by an inability of the tissue to utilize glucose and to 
synthesize protein. Hypoglycemia further reduced the tolerance to hypoxia, whereas 
the tolerance could be prolonged by reducing the energy requirements of cells 
(increasing magnesium in the medium). Ames postulated that the long period of 
tolerance of retinal neurons to complete anoxia in vitro, in comparison to that in 
vivo, is related to what he called the no-reflow phenomenon (swelling of capillary 
endothelial cells, which prevents the restoration of circulation), as mentioned earlier. 
Body temperature is yet another important factor in determining the extent of 
infarction. A reduction of even 2 to 3Â°C (3.6 to 5.4Â°F) reduces the metabolic 
requirements of neurons and increases their tolerance to hypoxia by 25 to 30 percent. 
These biochemical, cellular, and CBF findings enable one to conceptualize 
maneuvers for restoring blood flow within the marginally hypoperfused zone and 
salvaging brain tissue, particularly since under conditions of partial ischemia, 
cerebral tissue may survive for periods of 5 to 6 h or even longer. 
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THE MAJOR TYPES OF CEREBROVASCULAR DISEASE 
  
In classifying the cerebrovascular diseases, it is most practical, from the clinical 
viewpoint, to preserve the classic division into thrombosis, embolism, and 
hemorrhage. The causes of each of the big three, along with the criteria for diagnosis 
and the confirmatory laboratory tests for each, are considered here in separate 
sections. This classification has the disadvantage of not providing for disorders such 
as reversible ischemia, hypertensive encephalopathy, and venous thrombosis. 
 The frequency of the different types of cerebrovascular disease has been 
difficult to ascertain. Obviously clinical diagnosis is not always correct, and clinical 
services are heavily weighted with acute strokes and nonfatal cases of uncertain type. 
An autopsy series inevitably includes many old vascular lesions, particularly infarcts, 
whose exact nature cannot always be determined, and there is a bias also toward 
large fatal lesions (usually hemorrhages). As per Harvard Cooperative Stroke 
Registry, tabulated in 1978 and comprising 756 successive patients, each of whom 
was examined by a physician knowledgeable about strokes and subjected when 
necessary to appropriate ancillary examinations (four-vessel arteriography, CT scan, 
lumbar puncture, but before the days of MRI). For comparison, we have included an 
autopsy series of 740 cases, examined during the year 1949 by Fisher and Adams; of 
these, 179 (nearly 25 percent) had some form of cerebrovascular disease. 
Interestingly, in both series the ratio of infarcts to hemorrhages was 4:1 and 
Embolism accounted for approximately one-third of all strokes. The above studies 
correspond reasonably well with more recent data collated in the Stroke Data Bank 
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of the National Institute of Neurological and Communicative Disorders and Stroke 
(NINCDS) (Sacco et al, 1989) and other modern series which have had the 
advantage of MRI. 
Atherothrombotic Infarction 
 Most cerebrovascular disease can be attributed to atherosclerosis and chronic 
hypertension; until ways are found to prevent or control them, vascular disease of the 
brain will continue to be a major cause of morbidity. Hypertension and 
atherosclerosis interact in a variety of ways. Atherosclerosis, by reducing the 
resilience of large arteries, induces systolic hypertension. In turn, sustained 
hypertension worsens atherosclerosis, seemingly driving it into the walls of small 
branch arteries (0.5 mm or less). All the coats of the vessel become impregnated with 
a hyaline-lipid material, a process that Fisher has called lipohyalinosis. The segment 
so affected may also weaken and allow the formation of a small dissecting aneurysm 
(Charcot-Bouchard aneurysm), which most neuropathologists hold responsible for 
the hypertensive brain hemorrhage. 
 The atheromatous process in brain arteries is identical to that in the aorta, 
coronary, and other large arteries. In general the process in the cerebral arteries runs 
parallel to but is somewhat less severe than that in the aorta, coronary, and lower 
limb vessels. There are many exceptions to this rule, however, and not infrequently a 
brain artery becomes occluded when there is no clinical evidence of coronary or 
peripheral vascular disease. Although atheromatosis is known to have its onset in 
childhood and adolescence, only in the middle and late years of life is it likely to 
have clinical effects. Hypertension, hyperlipidemia, and diabetes greatly aggravate 
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the process. As with coronary and peripheral atherosclerosis, individuals with low 
blood levels of high-density-lipoprotein (HDL) cholesterol and high levels of low-
density-lipoprotein (LDL) cholesterol are particularly disposed to cerebral 
atherosclerosis (Nubiola et al). Long-duration cigarette smoking, an important factor 
in the genesis of atherosclerosis, decreases both HDL cholesterol and CBF (Ingall et 
al). Added to these well-established risk factors is a theorized role of an excess of 
homocystine and an even more speculative role for chronic inflammation or and 
intracellular infection of uncertain origin within plaques (Chlamydia pneumoniae has 
been implicated in some studies). Clinical experience indicates that there are families 
with a predilection for the development of cerebral atherosclerosis, independent of 
these well-defined risk factors. Obesity is also a risk factor, in part because of its 
correlation with diabetes. 
 There is a tendency for atheromatous plaques to form at branchings and 
curves of the cerebral arteries. The most frequent sites are in the internal carotid 
artery, at its origin from the common carotid; in the cervical part of the vertebral 
arteries and at their junction to form the basilar artery; in the stem or at the main 
bifurcation of the middle cerebral arteries; in the posterior cerebral arteries as they 
wind around the midbrain; and in the anterior cerebral arteries as they pass anteriorly 
and curve over the corpus callosum. It is rare for the cerebral arteries to develop 
plaques beyond their first major branching. Also, it is unusual for the cerebellar and 
ophthalmic arteries to show atheromatous involvement except in conjunction with 
hypertension. The common carotid and vertebral arteries at their origins from the 
aorta are frequent sites of atheromatous deposits, but because of abundant collateral 
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arterial pathways, occlusions at these sites are not commonly associated with 
cerebral ischemia. 
 The atheromatous lesions develop and grow silently for 20, 30, or more years; 
only in the event of a thrombotic complication do they become symptomatic. 
Although atheromatous plaques may narrow the lumen of an artery, causing stenosis, 
complete occlusion is nearly always the consequence of superimposed thrombosis 
atherothrombosis). In general, the more severe the atheromatosis, the more likely the 
thrombotic complication, but the two processes do not always run in parallel. One 
patient with only scattered atheromatous plaques may thrombose a vessel, whereas 
another with marked atherosclerosis may have only a few thrombosed vessels or 
none at all. Atheromatous lesions may regress to some extent under the influence of 
diet and certain drugs. Hennerici and colleagues followed a series of patients with 
carotid stenoses for a period of 18 months and observed spontaneous regression in 
nearly 20 percent of the lesions. In the large majority of cases, however, 
atherosclerosis is a progressive disease. 
 Degeneration of the wall of a sclerotic vessel or hemorrhage into the wall 
(from rupture of the vasa vasorum) may damage the endothelium. This is known to 
occur particularly in the walls of the internal carotid arteries (and the coronary 
arteries, where it is a main cause of vessel occlusion). The lesion in the atheromatous 
plaque apparently excites an inflammatory reaction. Platelets and fibrin then adhere 
to the damaged part of the wall and form delicate, friable clots, or a subintimal 
atheromatous deposit may slough, spewing crystalline cholesterol Emboli into the 
lumen with resulting occlusion of small distal vessels. In contrast to an Embolus, a 
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thrombus generally does not occlude the lumen completely from the first moment of 
its formation; total blockage may occur only after several hours. Once the lumen of 
the artery has been completely occluded, the thrombus may propagate distally and 
proximally to the next branching points and block an anastomotic channel. 
 These several dynamic events in the atherosclerotic-thrombotic process 
probably account for the prodromal ischemic attacks described below intermittent 
blockage of the circulation and variable impairment of function in the vascular 
territory, before proceeding to permanent ischemia. Not infrequently, several arteries 
are affected by stenosis and thrombosis over a period of months or years. Then it 
becomes difficult to decipher the interplay of factors that have led to either transitory 
or persistent symptoms. Some of the possibilities have been outlined by Adams and 
colleagues (1961). The evolution of the thrombotic process may be sufficiently 
prolonged to explain the clinical state known as stroke in evolution; when the 
hemodynamic disturbance stabilizes, the stage of completed stroke is reached. These 
different stages acquire significance in relation to therapy and prognosis. 
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Treatment of Atherothrombotic Infarction and Transient Ischemic Attacks 
 The main objective in these forms of cerebrovascular disease is the prevention 
of stroke. Ideally this should be accomplished by finding patients in the 
asymptomatic stage of atherosclerosis. However, the medical profession has no 
efficient means of screening large populations at risk of developing stroke and only 
limited methods for altering the progression of the atherosclerotic process, even if 
discovered in its early stages. The widespread use of cholesterol-lowering statin 
medications has been shown to reduce the incidence of stroke and will probably be 
more widely prescribed to normal older adults. For all practical purposes, treatment 
is directed to patients who have already begun to have symptoms, either TIAs or 
ischemic lesions that are reversible to some extent. 
 The current treatment of atherothrombotic disease may be divided into four 
parts: (1) management in the acute phase, (2) measures to restore the circulation and 
arrest the pathologic process, (3) physical therapy and rehabilitation, and (4) 
measures to prevent further strokes and progression of vascular disease. 
Management in the Acute Phase 
 The relative advantages of placing the seriously ill acute stroke patient in a 
neurologic special care or stroke unit have been the subject of many articles. It is our 
impression that the outcome in terms of morbidity and mortality in the seriously ill 
stroke patients improved, though admittedly this is difficult to document (for details, 
see Ropper and also Brott and Reed). Like the well-organized coronary care unit, 
stroke units have the capability of expediting the evaluation and early rehabilitation 
of these patients. As already emphasized, the prevention of aspiration and of 
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pneumonia are paramount, and probably avoidable. Also deserving attention are the 
prevention of venous thrombosis in the legs, pulmonary embolism, and coronary 
syndromes. Patients with impaired consciousness require special care of skin, eyes, 
mouth, bladder, and bowel. These measures are best provided in a unit with trained 
clinical staff and the technology to monitor blood pressure, pulmonary function, 
blood gases, and, when appropriate, intracranial pressure . 
Measures to Restore the Circulation and Arrest the Pathologic Process 
Once a thrombotic stroke has developed fully (i.e., the completed stroke), none of 
the therapeutic measures so far devised has proved to be consistently effective in 
restoring the damaged cerebral tissue to a functional state. The influence of 
anticoagulants and thrombolysis at an early stage of stroke are discussed below. 
One's efforts must be directed to making a diagnosis of thrombosis at the earliest 
possible stage and circumventing the full catastrophe by all means available without 
risking the safety of the patient. Even when the symptoms and signs have become 
persistent, it is conceivable that some of the affected tissue, particularly at the edges 
of the infarct, has not been irreversibly damaged and will survive if perfusion can be 
re-established. On the assumption that cerebral perfusion might be diminished by 
assuming the upright position, it is probably advisable for patients with a major 
stroke to remain nearly horizontal in bed for the first day. When sitting and walking 
begin, special attention should be given to maintenance of normal blood pressure 
(patients should avoid standing quietly or sitting with the feet down for prolonged 
periods, etc.). 
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 Several studies have confirmed the prevalence of new or exaggerated 
hypertension following an ischemic stroke and its tendency to decline within days 
even without medications. The treatment of previously unappreciated hypertension is 
preferably deferred until the neurologic deficit has stabilized. We agree with Britton 
and colleagues that it is prudent to avoid antihypertensive drugs in the first few days 
unless there is active myocardial ischemia or the blood pressure is high enough to 
pose a risk to other organs, particularly the kidneys, or there is a special risk of 
cerebral hemorrhage as a result of the use of thrombolytic drugs. 
Thrombolytic Agents 
 Tissue plasminogen activators (recombinant t-PA and streptokinase), when 
administered intravenously, convert plasminogen to plasmin, the latter being a 
proteolytic enzyme capable of hydrolyzing fibrin, fibrinogen, and other clotting 
proteins. These drugs are effective in the treatment of coronary artery occlusion (but 
are associated with a 1 percent risk of cerebral hemorrhage), and they also have now 
been shown to have a role in the treatment of stroke. 
 The multicenter study organized by the National Institute of Neurological and 
Communicative Disorders and Stroke (see the NINCDS and Stroke rt-PA Stroke 
Study Group in the References) has provided evidence of benefit from intravenous t-
PA. Treatment within 3 h of the onset of symptoms led to a 30 percent increase in 
the number of patients who remained with little or no neurologic deficit when re-
examined 3 months after the stroke and when assessed 1 year later in the study by 
Kwiatkowski et al. It is not easy to comprehend why the benefits apparently 
extended to all types of ischemic stroke, including those due to occlusion of small 
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vessels (lacunes), and why improvement was not at all apparent in the days 
immediately following treatment, only much later. The t-PA was administered in a 
dose of 0.9 mg/kg, 10 percent of which was given as an initial bolus, followed by an 
infusion of the remainder over 1 h. A dose of 90 mg was not exceeded, this being 
lower than the dose used for myocardial infarction. The relative improvement in 
neurologic state came at the expense of a 6 percent risk of symptomatic cerebral 
hemorrhage, i.e., a far lower rate than in most previous studies (some of the 
hemorrhages were into the area of infarction without causing symptomatic 
worsening). Patients with massive infarcts (ones that encompassed more than two-
thirds of the territory of the middle cerebral artery) or with high scores on a clinical 
stroke scale devised for the National Institutes of Health (NIH) study or with 
uncontrolled hypertension or who were more than 80 years of age or who had 
recently received anticoagulants (except aspirin) were excluded from this study. 
Further analysis of the NINCDS trial has revealed that patients who were treated 
earlier within the 3-h time frame had more benefit than those treated later; indeed, 
the administration of t-PA in the time period between 2.5 and 3 h after the stroke was 
of little value. 
 Comparable data from the randomized European Cooperative Acute Stroke 
Study (ECASS; see Hacke et al), which included 620 patients, identified two 
situations in which t-PA administered intravenously within 6 h, at a slightly higher 
dose than in the above trial (1.1 mg/kg, to a maximum of 100 mg), led to an 
improved neurologic outcome, but the overall results of this trial were considered  
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to be unfavorable largely because of a high rate of cerebral hemorrhage. In a second 
trial (ECASS II) in 800 patients, using the same dose as in the NINCDS-sponsored 
trial but giving the thrombolytic drug up to 6 h after the stroke, no benefit could be 
confirmed and the rate of symptomatic hemorrhage was 8.8 percent (compared with 
3.4 percent in untreated patients). Yet a subgroup of patients with carotid middle 
cerebral artery strokes of moderate severity specifically those with moderate-sized 
infarcts from occlusion of vessels distal to the carotid artery and adequate collateral 
circulation through surface vessels did appear to benefit. In some patients with 
basilar artery occlusion with coma of only brief duration and those without extensive 
thrombosis, prompt t-PA treatment also resulted in an overall improvement in 
neurologic function, but there were numerous exceptions. 
 In all these trials, patients with large cerebral infarctions had poor outcomes 
and suffered a high incidence of cerebral hemorrhage. It has been concluded, 
therefore, that the presence of blood in the first CT scan and evidence of extensive 
infarction, occupying most of the MCA territory, precludes this mode of therapy. In 
two similar trials conducted by the European MAST-I groups (see the Multicentre 
Acute Stroke Trial in References), using streptokinase within 6 h of stroke, there was 
actually an adverse outcome in the treated group having an excess of early deaths; 
this trial had a 21 percent incidence of symptomatic cerebral hemorrhage and an 18 
percent incidence of hemorrhagic infarctions. 
 At the present time the use of intravenous t-PA therapy can be advocated only 
in patients who arrive in the Emergency department and can be fully evaluated 
within 3 h of the onset of a stroke, preferably even earlier (thus excluding those who 
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awaken from a night's sleep with the symptoms) and have no hemorrhage on the CT 
scan. Generally also excluded are those in whom the deficit is either very small (e.g., 
hand affected only, dysarthria alone, minor aphasia) or, more importantly, so large as 
to implicate the entire territory of the middle cerebral artery. Although seemingly a 
promising approach to acute stroke, the use of acute thrombolytic therapy depends 
on the very early identification of a restricted group of patients; therefore this 
therapy is applicable to only a limited proportion of stroke patients who present to 
the Emergency department (approximately 5 percent) or those who have strokes 
while under observation in the hospital. It is noteworthy that attempts to reproduce 
the beneficial effects of t-PA in a community setting have been disappointing largely 
because of deviations from treatment guidelines and an excess number of 
hemorrhages (Katzan et al). Nonetheless, acute intravenous thrombolysis that is 
managed closely by experienced individuals using validated protocols is a 
compelling treatment at the moment for acute ischemic stroke. Public health 
education should increase the numbers of stroke patients who seek early attention 
and thus raise the proportion who are eligible for t-PA treatment. 
Thrombolytics injected intra-arterially can in some instances dissolve occlusions of 
the middle cerebral and basilar arteries and, if administered within hours, reduce the 
neurologic deficit. However, the routine intra-arterial injection of thrombolytics into 
infarcted tissue has produced a high incidence of cerebral hemorrhage, approaching 
20 percent in some studies and leaving the overall morbidity about the same in 
treated and untreated patients. There is also a high incidence of reocclusion of the 
treated vessel. The exception, in our limited experience, has been basilar artery 
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thrombosis without cerebellar infarctions, where large neurologic deficits are at 
times reversed with fewer complications. Treatment even several hours after the first 
symptoms may stop progression, but the lack of a systematic study of this approach 
makes it difficult to endorse without reservation. Mechanical lysis of an intra-arterial 
clot may be as effective. 
Causes of cerebral Embolism 
1. Cardiac origin 
a. Atrial fibrillation and other arrhythmias (with rheumatic, atherosclerotic, 
hypertensive, congenital, or syphilitic heart disease) 
 
b. Myocardial infarction with mural thrombus  
c. Acute and subacute bacterial endocarditis  
d. Heart disease without arrhythmia or mural thrombus (mitral stenosis, 
myocarditis, etc.) 
 
e. Complications of cardiac surgery  
f. Valve prostheses  
g. Nonbacterial thrombotic (marantic) endocardial vegetations  
h. Prolapsed mitral valve  
i. Paradoxical Embolism with congenital heart disease (e.g., patent foramen ovale)  
j. Myxoma  
2. Noncardiac origin  
a. Atherosclerosis of aorta and carotid arteries (mural thrombus, atheromatous 
material) 
 
b. From sites of dissection and/or fibromuscular dysplasia of carotid and 
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vertebrobasilar arteries 
c. Thrombus in pulmonary veins  
d. Fat, tumor, or air  
e. Complications of neck and thoracic surgery  
f. Pelvic and lower extremity venous thrombosis in presence of right-to-left cardiac 
shunt 
 
3. Undetermined origin  
 
 Another source of Embolism is the carotid or vertebral artery, where clot 
forming on an ulcerated atheromatous plaque may be detached and carried to an 
intracranial branch (artery-to-artery Embolism). A similar phenomenon may occur 
with arterial dissections and sometimes with fibromuscular disease of the carotid or 
vertebral arteries. 
 Atheromatous plaques in the ascending aorta have been recognized  in the last 
decades to be a more frequent source of Embolism than had been appreciated. 
Amarenco and colleagues reported that as many as 38 percent of a group of patients 
with no discernible cause for embolic stroke had echogenic atherosclerotic plaques 
in the aortic arch that were greater than 4 mm in thickness, a size thought to be 
associated on a statistical basis with strokes. Disseminated cholesterol emboli are 
known to occur in the cerebral circulation and may be dispersed in other organs as 
well; rarely, this is sufficiently severe to cause an encephalopathy and pleocytosis in 
the spinal fluid. 
Paradoxic embolism can occur when an abnormal communication exists between the 
right and left sides of the heart (particularly a patent foramen ovale, or PFO) or when 
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both ventricles communicate with the aorta; thus embolic material arising in the 
veins of the lower extremities or pelvis or elsewhere in the systemic venous 
circulation can bypass the pulmonary circulation and reach the cerebral vessels. 
Pulmonary hypertension (often from previous pulmonary embolism) favours the 
occurrence of paradoxic embolism, but this may occur with a PFO even in the 
absence of pulmonary hypertension. Of 30 patients in whom a PFO could be 
demonstrated, 17 had evidence of a right-to-left shunt; brain infarction was 
associated with positive phlebography of the legs and abnormal pulmonary 
scintigraphy (Itoh et al). Several studies indicated that the presence of a small atrial 
septal aneurysm adjacent to the patient foramen increases the likelihood of stroke. In 
the series of Mas and colleagues, patients ages 18 to 55 who had a stroke were 
followed for 4 years; the risk of second stroke was 2 percent in those with a PFO 
alone and 15 percent among those with both a PFO and an atrial septal aneurysm 
(curiously, the risk among those with neither congenital abnormality was 4 percent 
higher than for PFO). This mechanism comes into play mainly in considering the 
causes of stroke in the younger patient. Subendocardial fibroelastosis, idiopathic 
myocardial hypertrophy, cardiac myxomas, and cardiac lesions of trichinosis are rare 
causes of Ebolism. 
The vegetations of acute and subacute bacterial endocarditis give rise to several 
different lesions in the brain (page 606). Mycotic aneurysm is a rare complication of 
septic Embolism and may be a source of intracerebral or subarachnoid hemorrhage. 
Marantic or nonbacterial thrombotic endocarditis is a frequently overlooked cause of 
cerebral Embolism; at times it produces a baffling clinical picture, especially when 
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associated, as it often is, with carcinomatosis, cachexia from any cause, or lupus 
erythematosus.  
Mitral valve prolapse may be a source of emboli, especially in young patients, but its 
importance has probably been overestimated. The initial impetus for considering this 
abnormality as a source of embolus came from the study of Barnett and colleagues of 
a group of 60 patients who had TIAs or partial strokes and were under 45 years of 
age; prolapse was detected (by echocardiography and a characteristic midsystolic 
click) in 24 patients but in only 5 of 60 age-matched controls. However, in several 
subsequent large studies (Sandok and Giuliani and Jones et al), only a very small 
proportion of strokes in young patients could be attributed to prolapse; even then, the 
connection was only inferred by the exclusion of other causes of stroke. Indeed, in a 
recent study using stringent criteria for the echocardiographic diagnosis of prolapse, 
Gilon and colleagues could not establish any relation to stroke. Rice and colleagues 
have described a family with premature stroke in association with valve prolapse and 
a similar relationship has been reported in twins; the same may occur in Ehlers-
Danlos disease. 
The pulmonary veins are a potential if infrequent source of cerebral emboli, as 
indicated by the occurrence of cerebral abscesses in association with pulmonary 
suppurative disease and by the high incidence of cerebral deposits secondary to 
pulmonary carcinoma. In Osler-Weber-Rendu disease, pulmonary shunts serve as a 
conduit for emboli. As remarked above, surgery of the neck and thorax can be 
complicated by cerebral embolism. A rare type is that which follows thyroidectomy, 
where thrombosis in the stump of the superior thyroid artery extends proximally until 
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a section of the clot, protruding into the lumen of the carotid, is carried into the 
cerebral arteries. 
During cerebral arteriography, emboli may arise from the tip of the catheter, or 
manipulation of the catheter may dislodge atheromatous material from the aorta or 
carotid or vertebral arteries and account for some of the accidents during this 
procedure. Transcranial Doppler has suggested that small emboli frequently arise 
during these procedures; a study by Bendszus and colleagues found that 23 of 100 
consecutive patients had new cortical lesions shown on diffusion-weighted MRI just 
after cerebral arteriography. However, none of these were symptomatic and with 
good technique, emboli from vascular catheters are infrequent. 
Cerebral Embolism must always have occurred when secondary tumour is deposited 
in the brain, and cerebral embolism regularly accompanies septicaemia, but a mass 
of tumour cells or bacteria is seldom large enough to occlude a cerebral artery and 
produce the picture of stroke. Nevertheless, tumour embolism with stroke has been 
reported from cardiac myxomas and occasionally with other tumours. It must be 
distinguished from embolism due to marantic endocarditis that complicates 
malignant neoplasms (nonbacterial thrombotic endocarditis, discussed further on). 
Cerebral fat embolism is related to severe bone trauma. As a rule, the Emboli are  
minute and widely dispersed, giving rise first to pulmonary symptoms and then to 
multiple dermal (anterior axillary fold and elsewhere) and cerebral petechial 
hemorrhages. Accordingly, the clinical picture is more of an encephalopathy and not 
strictly focal, as it is in a stroke, although in some instances it may have focal 
features. Cerebral air embolism is a rare complication of abortion, scuba diving, or 
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cranial, cervical, or thoracic operations involving large venous sinuses; it was 
formerly encountered as a complication of pneumothorax therapy. Clinically, this 
condition may be difficult to separate from the deficits following hypotension or 
hypoxia, which frequently coexist. Hyperbaric treatment may be effective if 
instituted early. 
Despite the large number of established sources of emboli, the point of origin cannot 
be determined in about 30 percent of presumed embolic infarctions. In such cases, 
emboli may have originated from thrombi in the cardiac chambers but have left 
behind no residual clot and may be undetectable by even sophisticated methods such 
as trans-esophageal echocardiography and newer MR techniques. Others may be due 
to atheromatous material arising from the aorta. If extensive evaluation fails to 
disclose the origin, the odds still favour a source in the left heart. Not infrequently 
the diagnosis of cerebral Ebolism is made at autopsy without finding a source. The 
search for a thrombotic nidus may not have been sufficiently thorough in these cases, 
and small thrombi in the atrial appendage, endocardium (between the papillary 
muscles of the heart), the aorta and its branches, or pulmonary veins may have been 
overlooked. Nevertheless, in some cases, even when studied carefully postmortem, 
no source of embolic material can be discovered. 
LESS COMMON CAUSES OF OCCLUSIVE CEREBROVASCULAR DISEASE 
Fibromuscular Dysplasia 
This is a segmental, nonatheromatous, noninflammatory arterial disease of unknown 
etiology. It is uncommon (0.5 percent of 61,000 arteriograms in the series of So et 
al), but it is being reported with increasing frequency because of improved 
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arteriographic techniques. In our experience, it has often been an incidental finding 
in asymptomatic individuals undergoing aortic angiography. 
First described in the renal artery by Leadbetter and Burkland in 1938, fibromuscular 
dysplasia is now known to affect other vessels, including cervicocerebral ones. The 
internal carotid artery is involved most frequently, followed by the vertebral and 
cerebral arteries. The radiologic picture consists of a series of transverse 
constrictions, giving the appearance of an irregular string of beads or a tubular 
narrowing; it is observed bilaterally in 75 percent of cases. Usually only the 
extracranial part of the artery is involved. In the series of Houser and colleagues, 42 
of 44 patients were women, and 75 percent were over 50 years of age. All of the 
patients reported by So and coworkers were women, ranging in age from 41 to 70 
years. Cerebral ischemia may be associated with the process but the rate of this 
complication has not been established. Our impression is that it is low. Among 79 
untreated asymptomatic patients followed for an average of 5 years, 3 had a cerebral 
infarct 4 to 18 years after the initial diagnosis in the study by Corrin et al. Also, 
between 7 and 20 percent of affected individuals are found to have intracranial 
saccular aneurysms (rarely a giant aneurysm), which may be a source of 
subarachnoid hemorrhage, and 12 percent develop arterial dissections, as described 
below. 
The pathology of this disease has been summarized by Schievink and colleagues. 
The narrowed arterial segments show degeneration of elastic tissue and irregular 
arrays of fibrous and smooth muscle tissue in a mucous ground substance. 
Dilatations are due to atrophy of the coat of the vessel wall. There is atherosclerosis  
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in some and arterial dissection in others. Usually vascular occlusion is not present, 
though there may be marked stenosis. In some instances the mechanism of the 
cerebral ischemic lesion is unexplained. Possibly thrombi form in the pouches or in 
relation to intraluminal septa. 
So and colleagues have recommended excision of the affected segments of the 
carotid artery if the neurologic symptoms are related to them and conservative 
therapy if the fibromuscular dysplasia is an incidental arteriographic finding in an 
asymptomatic patient. It is now possible to dilate the affected vessel by means of 
endovascular techniques, and several case reports have suggested that benefit is 
achieved at lower risk in this way than with surgical excision. Associated intracranial 
saccular aneurysms should be sought by arteriography or magnetic resonance 
angiography and surgically obliterated if their size warrants it (page 722). It is not 
known if anticoagulation or antiplatelet therapy confer protection from stroke. 
Dissection of the Cervical and Intracranial Vessels 
Internal Carotid Artery Dissection 
It has long been appreciated that the process formerly known as Erdheim's 
medionecrosis aortica cystica, the main cause of aortic dissection, may extend into 
the common carotid arteries, occluding them and causing massive infarction of the 
cerebral hemispheres. Examples of such an occurrence were cited by Weisman and 
Adams in 1944 in their study of the neurology of dissecting aneurysms of the aorta. 
In more recent years, attention has been drawn to the occurrence of spontaneous 
dissection of the internal carotid artery and the fact that it is an important cause of 
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hemiplegia in young adults. Several large series of such cases have been reported in 
separate studies by Ojemann, Mokri, and Bogousslavsky and their colleagues. 
Traumatic or apparently spontaneous carotid dissection is a not uncommon cause of 
stroke, particularly in younger individuals. Bogousslavsky and colleagues found 30 
instances (comprising both genders) in 1200 consecutive patients with a first stroke 
(2.5 percent). It should be suspected in young adult women (typically in their late 
thirties or early forties), who seem especially susceptible to the condition, either as a 
spontaneous event or in relation to a whiplash injury, bouts of violent coughing, or 
direct trauma to the head or neck, which need not be severe e.g., being struck in the 
neck by a golf or tennis ball. We have also encountered cases that occurred during 
pregnancy and immediately after delivery. Indeed, it is questionable if many cervical 
arterial dissections are truly spontaneous, since most can be connected to some 
strenuous event. Three of our patients over the years had a carotid dissection that 
was manifest as a hemiplegia days after blunt head injury. A small number of 
patients have fibromuscular disease, as discussed above; the Ehlers-Danlos and 
Marfan syndromes, osteogenesis imperfecta, and alpha-1-antitrypsin deficiency are 
also associated with an increased risk of vascular dissection. One of these conditions 
should be suspected if multiple extracranial vessels are involved in spontaneous 
dissections (neck and thoracic trauma are more common causes of this 
configuration). 
 It is of interest that a few patients with carotid dissection have had warning 
attacks of unilateral cranial or facial pain, followed, within minutes to days, by signs 
of ischemia in the territory of the internal carotid artery. The pain is nonthrobbing 
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and centered most often in and around the eye; less often, it is in the frontal or 
temporal regions, angle of the mandible, or high anterior neck over the carotid artery. 
Rapid and marked relief of the pain after the administration of corticosteroids is 
virtually a diagnostic feature (see below). The ischemic manifestations consist of 
transient attacks in the territory of the internal carotid, followed frequently by the 
signs of hemispheral stroke, which may evolve smoothly over a period of a few 
minutes to hours or over several days in a fluctuating or stepwise fashion. A 
unilateral Horner syndrome is often present. Cervical bruitsometimes audible to the 
patient, amaurosis fugax, faintness and syncope, and facial numbness are less 
common symptoms. Most of the patients described by Mokri and coworkers 
presented with one of two distinct syndromes: (1) unilateral headache associated 
with an ipsilateral Horner syndrome or (2) unilateral headache and delayed focal 
cerebral ischemic symptoms. Some patients have evidence of involvement of the 
vagus, spinal accessory, or hypoglossal nerve; these nerves lie in close proximity to 
the carotid artery and are nourished by small branches from it. 
In most cases, dissection of the internal carotid artery can be detected by ultrasound 
and confirmed by MRI, which shows a double lumen, and by MRA. These 
procedures may obviate the need for arteriography. The latter procedure reveals an 
elongated, irregular, narrow column of dye, usually beginning 1.5 to 3 cm above the 
carotid bifurcation and extending to the base of the skull, a picture that Fisher has 
called the string sign. There may be a tapered occlusion or an outpouching at the 
upper end of the string. Less often the dissection is confined to the midcervical 
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region, and occasionally it extends into the middle cerebral artery or involves the 
opposite carotid artery or the vertebral and basilar arteries. 
The extensive study by Mokri and colleagues showed that a complete or excellent 
recovery occurred in 85 percent of patients with the angiographic signs of dissection; 
mainly, these were patients without stroke. The outcome in cases complicated by 
stroke is far less benign. About one-quarter of such patients succumb and one-half of 
the survivors remain seriously impaired (Bogousslavsky et al). In the remainder, 
early recanalization of the occluded artery can be observed (as determined by 
ultrasonography), with good functional recovery. Pseudoaneurysms form in a small 
proportion of patients and generally do not require surgical repair; they also do not 
preclude cautious anticoagulation. 
The pathogenesis of spontaneous carotid dissection is at present uncertain. In most of 
the recently reported cases, cystic medial necrosis has not been found on 
microscopic examination of the involved artery. In some, there was a disorganization 
of the media and internal elastic lamina, but the specificity of these changes is in 
doubt, since Ojemann and colleagues noted similar changes in some of their control 
cases. In a small proportion of cases there are the changes of fibromuscular 
dysplasia, as noted earlier. A more thorough study of these vessels in routine autopsy 
material is needed. 
Treatment 
The treatment has usually been immediate anticoagulation to prevent Ebolismusing 
first heparin, then warfarinbut it must be acknowledged that this approach has not 
been demonstrated to be more successful than careful observation. Once a stroke has 
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occurred, even though Ebolic in most cases, prompt reopening of the artery can at 
times prove beneficial; this is currently performed by endovascular techniques. 
Despite numerous publications demonstrating the ability of skilled operators to 
reopen a dissection by endovascular methods, acute intervention has not been studied 
in a way that allows a judgment regarding its value. Whether stent placement is 
additionally beneficial has also not been determined. Interesting, and of both 
therapeutic and diagnostic value, is the relief of pain afforded by corticosteroids in 
cervical and intracranial dissections, as mentioned above. Most neurologists take the 
approach that warfarin, if used, may be discontinued after several months or a year, 
when angiography or MRA shows the lumen of the carotid artery to be patent, or at 
least reduced to no more that 50 percent of the normal diameter, and smooth-walled. 
Familial Subcortical Infarction (CADASIL) 
A process similar to Binswanger leukoencephalopathy, but without hypertension, has 
been identified as an autosomal dominant familial trait linked in several families to a 
mutation on chromosome 19. It had been described previously under a number of 
names, including hereditary multi-infarct dementia. The acronym CADASIL 
(cerebral autosomal dominant arteriopathy with subcortical infarcts and 
leukoencephalopathy) is now applied. In these patients, recurrent small strokes, often 
beginning in early adulthood, culminate in a subcortical dementia. Migraine 
headaches, often with neurologic accompaniments, may precede the strokes by 
several years, as may numerous and varied TIAs that are attributed, probably 
incorrectly, to the migraine. Some individuals display few clinical changes; others 
are demented or have strokes that simulate lacunes. We are unable to comment on 
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the encephalopathy and coma, in some cases accompanied by fever, described by 
Schon and colleagues. It seems to represent another very rare condition. 
The familial nature of the process may not be appreciated because genetic penetrance 
is not complete until after 60 years of age. On MRI scans, clinically unaffected 
family members may show substantial changes in the white matter well before 
strokes or dementia arises. In some cases, particularly in Japan, early alopecia and 
lumbar spondylosis have been associated with CADASIL. 
The MRI and CT appearance of multiple confluent white matter lesions of various 
sizes, many quite small and concentrated around the basal ganglia and 
periventricular areas, is similar to that in Binswanger disease. When these are 
asymmetrical and periventricular, they are difficult to distinguish from the lesions of 
multiple sclerosis. In the autopsy cases studied by Jung and colleagues, numerous 
partially cavitated infarctions were found in the white matter and basal ganglia. In 
the regions of these infarctions were small vessels, 100 to 200 mm diameter, in 
which the media contained basophilic granular deposits with degeneration of the 
smooth muscle fibers. Attribution of the white matter degeneration to these vascular 
changes presents the same problems as in Binswanger disease, particularly in view 
of patency of most of the many small vessels in the material. Again, the relation of 
the vascular changes to lesions in the brain has not been studied in serial sections. 
Nevertheless, CADASIL is probably the main cause of sporadic instances of what 
otherwise passes for Binswanger disease but without the obligate hypertension of the 
latter. Also, migraine headaches are not a component of Binswanger disease. 
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The responsible mutation on chromosome 19 of the Notch 3 gene, in the same locus 
as the gene for familial hemiplegic migraine, has been characterized by Joutel and 
colleagues; this provides a diagnostic test that can be performed on the blood or skin. 
However, the mechanism by which this leads to the vasculopathy or white matter 
changes is not clear. The diagnosis can also be confirmed by finding eosinophilic 
inclusions in the arterioles of a skin biopsy (osmophilic with electron microscopy). 
Awareness of this apparently vascular form of white matter degeneration adds to the 
list of inherited leukoencephalopathies, the others being inherited metabolic 
disturbances. 
Amyloid Angiopathy 
 This process is discussed further on in relation to lobar cerebral hemorrhages 
in the elderly. The angiopathy consists of the deposition of amyloid in the media and 
adventitia of small vessels, predominantly in the meninges, cortex, and cortical 
penetrating vessels. The incidence at autopsy of vascular amyloid deposition in the 
brain is related to the age of the population studied; rates of 12 percent are cited in 
patients above 85 years of age (the same changes are present in over 25 percent of 
individuals with Alzheimer disease, but the nature of the amyloid is different in the 
two conditions). Over the last few years, however, our colleague Greenberg has 
emphasized certain clinical features associated solely with cerebrovascular 
amyloidosis. Of interest here are multiple TIAs, some with migrainous features such 
as spreading sensory symptoms, and fairly rapid progression to dementia. Telltale 
signs of small hemorrhages that are more characteristic of diffuse cerebrovascular 
amyloid are often present in these cases. These old hemorrhages are seen to 
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advantage with gradient echo sequences on the MRI. The frequency of this 
interesting condition in the elderly is unclear. There is a separate familial 
amyloidotic condition of diffuse white matter degeneration with dementia, associated 
in some families with calcification in the occipital lobes. 
Strokes in Children and Young Adults 
 it is probable that ischemic necrosis of cerebral tissue can occur in utero. The 
resulting stroke is usually referred to as congenital hemiplegia. However, very little 
is known about the underlying vascular lesions, so that nothing further can be said 
about them here. 
The occurrence of acute hemiplegia in infants and children is a well-recognized 
phenomenon. In a series of 555 consecutive postmortem examinations at the 
Children's Medical Centre in Boston, there were 48 cases (8.7 percent) of occlusive 
vascular disease of the brain (Banker). The occlusions were both embolic (mainly 
associated with congenital heart disease) and thrombotic, and the latter were actually 
more common in veins than in arteries. Similarly, stroke is not an uncommon event 
in young adults (15 to 45 years). This group accounts for an estimated 3 percent of 
cerebral infarctions. In terms of causation, this group is remarkably heterogeneous. 
In a series of 144 such patients, more than 40 possible etiologies were identified (H. 
P. Adams et al). Nevertheless, 78 percent of the group could be accounted for by 
three categories, more or less equal in size: atherosclerotic thrombotic infarction 
(usually with a recognized risk factor); cardiogenic Embolism (particularly in 
association with rheumatic heart disease, bacterial and verrucous endocarditis, 
paradoxic Embolism through patent foramen ovale, and prosthetic valves); and 
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nonatherosclerotic vasculopathies (arterial trauma, dissection of the carotid artery, 
moyamoya, lupus erythematosus, drug-induced, vasculitis). Hematologically related 
disorders, use of oral contraceptives, the postpartum state, and hypercoagulable 
states were the probable causes in 15 percent of the 144 patients. The presence of 
antiphospholipid or anticardiolipin antibodies (lupus anticoagulant) appears to 
explain some of these cases and is discussed further under Stroke as a Complication 
of Haematologic Disease; the majority of these patients are women in their thirties 
without manifesting systemic lupus erythematosus. 
Despite the attention they have received as a cause of strokes in the juvenile period, 
the frequency of thrombophilic disorders due to inherited deficiencies of naturally 
occurring anticoagulant factors is low. They predispose primarily to cerebral venous 
clotting. Most arise from partial protein deficiencies due to heterozygous mutations 
in the genes encoding proteins that are important factors in the clotting cascade 
(antithrombin III, proteins S and C) and those due to disturbances of clotting balance 
(resistance to activated protein C, or factor V Leiden mutation, and prothrombin 
mutations as well as excess factor VIII) (see discussion by Brown and Bevan). 
However, when they are homozygous, these mutations may be associated with 
devastating neonatal hemorrhagic conditions. In some series that report cases of 
strokes in youth, such that of Becker and colleagues, up to half of the cases had one 
of these disorders, the commonest being the factor V Leiden mutation, but others 
have found this mutation to be much less frequent, and that is consonant with our 
experience. Nevertheless, in children with unexplained stroke, particularly venous 
and especially if there has been a previous thrombosis or if the strokes are recurrent, 
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it is advisable to carry out an extensive hematologic investigation, especially 
including testing for antiphospholipid antibody (an acquired defect), as described on 
page 735. Establishing a diagnosis of a prothrombotic clotting gene variant has 
therapeutic significance, since strokes are prone to occur in the setting of such 
additional risks as the use of oral contraceptives or smoking. In adults, the evaluation 
for inherited clotting defects is far less fruitful. Furthermore, it should be kept in 
mind that the levels of proteins C and S and of antithrombin are temporarily 
depressed after stroke, so that any detected abnormalities must be confirmed months 
later. 
 
Stroke associated with genetic disorders 
 GENE 
INHERI 
TANCE 
STRUC 
TURES 
AFFECTED 
GENERAL 
POPU 
LATION 
(%) 
WITH 
CEREBRAL 
THROMBOSIS 
(%) 
Causes of arterial or venous infarction 
Activated protein C 
resistance 
Leiden factor V 
mutation 
AR v 2-15 5-20 
Prothrombin 20210 Prothrombin AR v 0.1 1-5 
Protein C deficiency Protein C gene AR v 0.2-0.4 3-6 
Protein S deficiency Protein S gene AR v 0.03-0.13 1-5 
Increased Factor VIII von Willebrand 
factor deficiency 
AR v 10 25 
Antithrombin III 
deficiency 
Antithrombin III AR v Rare 3-8 
Plasminogen deficiency Plasminogen 
activator-1 
AR v   
Lipoprotein (a) Apolipoprotein (a) AR v   
Marfan syndrome Fibrillin 1  v,h,ao 0.03  
Fabry disease Alpha-galactosidase AR v   
Sickle cell syndrome Globin genes  v,a   
Heparin cofactor II Heparin cofactor II AR v Rare ? 5 
Platelet collagen 
receptor 
Platelet collagen 
receptor 
AR v   
Factor XII Factor XII AR v   
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Phosphodiesterase 4D Phosphodiesterase 
4D 
Complex a   
CADASIL Notch 3 AD a   
Hyperhomocysteinemia Methylene 
tetrahydrofolate 
reductase 
AR a Rare 20 in young 
Homocysteinemia Cystathione beta-
synthase 
AR a   
Homocysteinemia Homocysteine 
methyl transferase 
AR a   
Ehlers Danlos disease   a   
MELAS 
(mitochondrial): 
mtDNA Maternal    
Causes of cerebral hemorrhage associated with congenital diseases 
von Hippel-Lindau 
(Chap. 31) 
pVHL AD hemorrhage   
Cavernous 
malformations 
Cerebral cavernous 
malformations 
(CCM1) 
AD    
Cerebral amyloidosis Apolipoprotein E4 Complex    
Cerebral hemorrhage 
with amyloidosis 
     
Dutch type Amyloid precursor 
protein 
AD    
Icelandic type Cystatin C AD    
Hereditary hemorrhagic 
telangiectasia 
Endoglin AD    
Hereditary hemorrhagic 
telangiectasia 
Activin receptor-
like kinase (ALK-1) 
AD    
Polycystic kidney 
disease 
Polycystin 1, 2 AD    
Key: AD, autosomal dominant; AR, autosomal recessive; v, venous; a, arterial; ao, aorta; h, 
heart. 
 
 
 Persistent cerebral ischemia and infarction may occasionally complicate 
migraine in young persons. The combination of migraine and the Pill is particularly 
hazardous, as detailed below. Similarly, despite the common occurrence of mitral 
valve prolapse in young adults, it is probably only rarely a cause of stroke. Stroke 
due to either arterial or venous occlusion occurs occasionally in association with 
ulcerative colitis and to a lesser extent with regional enteritis. Evidence points to a 
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hypercoagulable state during exacerbations of inflammatory bowel disease, but a 
precise defect in coagulation has not been identified. Meningovascular syphilis and 
fungal and tuberculous meningitis and other forms of chronic basal meningitis are 
considerations in this age group; the strokes are usually of the cavitary lacunar type, 
resulting from infectious-inflammatory occlusion of small basal vessels. 
INTRACRANIAL HEMORRHAGE 
 This is the third most frequent cause of stroke. Although more than a dozen 
causes of non traumatic intracranial haemorrhage, primary or hypertensive 
spontaneous intracerebral hemorrhage, ruptured saccular aneurysm and vascular 
malformation, and hemorrhage associated with the use of anticoagulants or 
thrombolytic agents account for the majority. Cerebrovascular amyloidosis and 
bleeding disorders account for a small number. The small brainstem hemorrhages 
secondary to temporal lobe herniation and brainstem compression (Duret 
hemorrhages), hypertensive encephalopathy, and brain purpura might be included in 
this group, but they do not simulate a stroke. 
Causes of intracranial hemorrhage (including intracerebral, subarachnoid, 
ventricular, and subdural) 
1. Primary (hypertensive) intracerebral haemorrhage 
2. Ruptured saccular aneurysm 
3. Ruptured AVM; less often, venous and dural vascular malformations 
4. Cavernous angioma 
5. Trauma including posttraumatic delayed apoplexy 
6. Haemorrhagic disorders: leukaemia, aplastic anemia, thrombocytopenic purpura, 
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liver disease, complication of anticoagulant or thrombolytic therapy, 
hypofibrinogenemia, hemophilia, Christmas disease, etc. 
7. Haemorrhage into primary and secondary brain tumors 
8. Septic Embolism, mycotic aneurysm 
9. With hemorrhagic infarction, arterial or venous 
10. With inflammatory and infectious disease of the arteries and veins 
11. With arterial amyloidosis 
12. Miscellaneous rare types: vasopressor drugs, cocaine, moya moya, herpes 
simplex encephalitis, vertebral artery dissection, acute necrotizing hemorrhagic 
encephalitis (Hurst disease), tularemia, anthrax, etc. 
 
 
 
Primary (Hypertensive) Intracerebral Haemorrhage 
This is the mundane spontaneous brain hemorrhage. It is due predominantly to 
chronic hypertension and degenerative changes in cerebral arteries. In recent 
decades, with increased awareness of the need to control blood pressure, the 
proportion of hemorrhages attributable to causes other than hypertension has greatly 
increased; more than half such hemorrhages on our services now occur in 
normotensive individuals, and the hemorrhages more often than previously arise in 
locations that are not typical for hypertension. Nevertheless, the hypertensive 
cerebral hemorrhage serves as a paradigm for understanding and managing the 
cerebral hemorrhage. 
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 In order of frequency, the most common sites of a cerebral hemorrhage are (1) 
the putamen and adjacent internal capsule (50 percent); (2) the central white matter 
of the temporal, parietal, or frontal lobes (lobar hemorrhages, not strictly associated 
with hypertension); (3) the thalamus; (4) a cerebellar hemisphere; and (5) the pons 
(see Weisberg et al). The vessel involved is usually a penetrating artery that 
originates from a larger trunk vessel. About 2 percent of primary hemorrhages are 
multiple. Rarely the bleeding is solely intraventricular, possibly from the choroid 
plexus. The problem is one of bleeding that occurs within brain tissue; rupture of 
arteries lying in the subarachnoid space is practically unknown apart from aneurysms 
and some vascular malformations. 
 The extravasation of blood forms a roughly circular or oval mass that disrupts 
the tissue and grows in volume as the bleeding continues (Fig. 34-20). Adjacent 
brain tissue is distorted and compressed. If the hemorrhage is large, midline 
structures are displaced to the opposite side and reticular activating and respiratory 
centers can be compromised, leading to coma and death in the manner described in 
Chap. 17. Both the size and the location of the clot determine the degree of upper 
brainstem compression (Andrew et al). Rupture or seepage into the ventricular 
system may occur, and the CSF becomes bloody in these cases. However, a 
hemorrhage of this type almost never ruptures through the cerebral cortex. When the 
hemorrhage is small and located at a distance from the ventricles, the CSF may 
remain clear even on repeated examinations.  
 In the first hours and days following the hemorrhage, a limited amount of 
edema accumulates around the clot and adds to the mass effect. Hydrocephalus may 
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occur as a result of bleeding into the ventricular system or from compression of the 
third ventricle. 
 Extravasated blood undergoes a predictable series of changes. At first fluid, it 
clots within hours. Before the clot forms, red cells may settle in the dependent part of 
the hematoma and form a meniscus with the plasma above; this is particularly prone 
to occur in cases of anticoagulant-induced hemorrhage. A fluid-fluid level is then 
observed on scans hematocrit effect). Only masses of red blood cells (RBCs) and 
proteins are found within the hematoma; rarely one sees a few remnants of destroyed 
brain tissue. The hematoma is surrounded by petechial hemorrhages from torn 
arterioles and venules. Within a few days, hemoglobin products, mainly hemosiderin 
and hematoidin, begin to appear. The hemosiderin forms within histiocytes that have 
phagocytized RBCs and takes the form of ferritin granules, which stain positively for 
iron. As oxyhemoglobin is liberated from the RBCs and becomes deoxygenated, 
methemoglobin is formed. This begins within a few days and imparts a brownish hue 
to the periphery of the clot. Phagocytosis of RBCs begins within 24 h, and 
hemosiderin is first observed around the margins of the clot in 5 to 6 days. The clot 
changes color gradually, over a few weeks, from dark red to pale red, and the border 
of golden-brown hemosiderin widens. The edema disappears over many days or 
weeks. In 2 to 3 months, larger clots are filled with a chrome-colored mush, which is 
slowly absorbed, leaving a smooth-walled cavity (slit hemorrhage) or a yellow-
brown scar. The iron pigment (hematin) becomes dispersed and studs adjacent 
astrocytes and neurons. It may persist well beyond the border of the hemorrhage for 
years. 
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 In CT scans, fresh blood is visualized as a white mass as soon as it is shed. 
The mass effect and the surrounding extruded serum and edema are hypodense. 
After 2 to 3 weeks, the surrounding edema begins to recede and the density of the 
hematoma decreases, first at the periphery. Gradually the clot becomes isodense with 
brain. There may be a ring of enhancement from the hemosiderin-filled macrophages 
and the reacting cells forming the capsule of the hemorrhage. By MRI, either in 
conventional T1- or T2-weighted images, the hemorrhage is not easily visible in the 
2 or 3 days after bleeding, since oxyhemoglobin is diamagnetic or, at most, is 
slightly hypointense, so that only the mass effect is evident. After several days the 
surrounding edema is hyperintense in T2-weighted images. As deoxyhemoglobin 
and methemoglobin form, the hematoma signal becomes bright on T1-weighted 
images and dark on T2. As the hematoma becomes subacute, the dark images 
gradually brighten. When methemoglobin disappears and only hemosiderin remains, 
the entire remaining mass is hypodense on T2-weighted images, as are the 
surrounding deposits of iron. MR images that display areas of magnetic 
susceptibility will show hemorrhages earlier and detect remnants of deposited 
hemosiderin even years afterwards. 
 Hemorrhages may be described as massive, moderate, small, slit, and 
petechial. Massive refers to hemorrhages several centimeters in diameter; small 
applies to those 1 to 2 cm in diameter and less than 20 mL in volume; a moderate-
sized hemorrhage, of course, falls between these two, both in diameter and in 
volume. Slit refers to an old collapsed hypertensive or traumatic hemorrhage that lies 
just beneath the cortex. 
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Pathogenesis 
 The hypertensive vascular lesion that leads to arterial rupture in some cases 
appears to arise from an arterial wall altered by the effects of hypertension, i.e., the 
change referred to in a preceding section as segmental lipohyalinosis and the false 
aneurysm (microaneurysm) of Charcot-Bouchard. Ross Russell has affirmed the 
relationship of these microaneurysms to hypertension and hypertensive hemorrhage 
and their frequent localization on penetrating small arteries and arterioles of the basal 
ganglia, thalamus, pons, and subcortical white matter. However, in the few 
hemorrhages examined in serial sections by our colleague C. M. Fisher, the bleeding 
could not be traced to Charcot-Bouchard aneurysms. Takebayashi and coworkers, in 
an electron microscopic study, found breaks in the elastic lamina at multiple sites, 
almost always at bifurcations of the small vessels. Possibly these represent sites of 
secondary rupture from tearing of small vessels by the expanding hematoma. 
Putaminal Haemorrhage 
The most common syndrome is the one due to putaminal hemorrhage, with extension 
to the adjacent internal capsule (Fig. 34-20). The neurologic symptoms and signs 
vary slightly with the precise site and size of the extravasation, but hemiplegia from 
interruption of the capsule is a consistent feature of medium-sized and large clots. 
Vomiting occurs in about half the patients. Headache is frequent but not invariable. 
With large hemorrhages, patients lapse almost immediately into a stupor with 
hemiplegia, and their condition visibly deteriorates as the hours pass. More often, 
however, the patient complains of headache or of some other abnormal cephalic 
sensation. Within a few minutes the face sags on one side, speech becomes slurred or 
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aphasic, the arm and leg gradually weaken, and the eyes tend to deviate away from 
the side of the paretic limbs. These events, occurring gradually over a period of a 
few minutes to a half hour, are strongly suggestive of intracerebral bleeding. The 
paralysis may worsen; a Babinski sign appears, at first unilaterally and then 
bilaterally; the affected limbs become flaccid; painful stimuli are not appreciated; 
speaking becomes impossible; and confusion gives way to stupor. The most 
advanced stages are characterized by signs of upper brainstem compression (coma); 
bilateral Babinski signs; deep, irregular, or intermittent respiration; dilated, fixed 
pupils, first on the side of the clot; and occasionally by decerebrate rigidity. 
The widespread use of CT scanning has disclosed the frequent occurrence of smaller 
putaminal hemorrhages, which in former times would have been misdiagnosed as 
Ebolic or thrombotic ischemic strokes (especially if the CSF was clear). With 
hemorrhages confined to the anterior segment of the putamen, the hemiplegia and 
hyperreflexia tend to be less severe and to clear more rapidly (Caplan). There is also 
prominent abulia, motor impersistence, temporary unilateral neglect, and with left-
sided lesions, nonfluent aphasia and dysgraphia. With posterior lesions, weakness is 
also less and is attended by sensory loss, hemianopia, impaired visual pursuit to the 
opposite side, Wernicke-type aphasia (left-sided lesions), and anosognosia (right-
sided). 
Caplan has also analyzed the effects of relatively pure caudate hematoma. Those 
extending laterally and posteriorly into the internal capsule behave much like large 
putaminal hemorrhages. Those extending medially into the lateral ventricle give rise 
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to drowsiness, stupor, and either confusion and underactivity or restlessness and 
agitation. 
Thalamic Haemorrhage 
The central feature here is severe sensory loss on the entire contralateral body. If 
large or moderate in size, thalamic hemorrhage also produces a hemiplegia or 
hemiparesis by compression or destruction of the adjacent internal capsule (Fig. 34-
21). The sensory deficit is usually severe and involves all of the opposite side, 
including the trunk, and may exceed the motor weakness. A fluent aphasia may be 
present with lesions of the dominant side, and amorphosynthesis and contralateral 
neglect with lesions of the nondominant side. A homonymous field defect, if present, 
usually clears in a few days. 
 Thalamic hemorrhage, by virtue of its extension into the subthalamus and 
high midbrain, may cause a series of ocular disturbances pseudo-abducens palsies 
with one or both eyes turned asymmetrically inward and slightly downward, palsies 
of vertical and lateral gaze, forced deviation of the eyes downward, inequality of 
pupils with absence of light reaction, skew deviation with the eye ipsilateral to the 
hemorrhage assuming a higher position than the contralateral eye, ipsilateral ptosis 
and miosis (Horner syndrome), absence of convergence, retraction nystagmus, and 
tucking in (retraction) of the upper eyelids. Extension of the neck may be observed. 
Compression of the adjacent third ventricle leads to enlargement of the lateral 
ventricles, and this requires temporary drainage of the ventricles in a small 
proportion of patients. Small and moderate-sized hemorrhages that rupture into the 
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third ventricle are seemingly associated with fewer neurologic deficits and better 
outcomes, but early hydrocephalus is almost invariable. 
Pontine Haemorrhage 
 Here deep coma usually ensues in a few minutes, and the clinical picture is 
dominated by total paralysis, decerebrate rigidity, and small (1-mm) pupils that react 
to light. Lateral eye movements, evoked by head turning or caloric testing, are 
impaired or absent. Death usually occurs within a few hours, but there are rare 
exceptions in which consciousness is retained and the clinical manifestations indicate 
a smaller lesion in the tegmentum of the pons (disturbances of lateral ocular 
movements, crossed sensory or motor disturbances, small pupils, and cranial nerve 
palsies) in addition to signs of bilateral corticospinal tract involvement. A small 
number of our patients with small tegmental hemorrhages and blood in the CSF have 
survived, with good functional recovery. In a series of 60 patients with pontine 
hemorrhage reviewed by Nakajima, 19 survived (8 of these had remained alert). 
Similarly, Wijdicks and St. Louis reported that 21 percent made a good 
recoverymostly those who were alert on admission. 
Cerebellar Haemorrhage 
 This usually develops over a period of one to several hours, and loss of 
consciousness at the onset is unusual. Repeated vomiting is a prominent feature, 
along with occipital headache, vertigo, and inability to sit, stand, or walk. Often 
these are the only abnormalities, making it imperative to have the patient attempt to 
stand and walk; otherwise the examination may be falsely normal. In the early phase 
of the illness, other clinical signs of cerebellar disease may be minimal or lacking; 
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only a minority of cases show nystagmus or cerebellar ataxia of the limbs, although 
these signs must always be sought. A mild ipsilateral facial weakness and a 
diminished corneal reflex are common. Dysarthria and dysphagia may be prominent 
in some cases but usually are absent. Contralateral hemiplegia and ipsilateral facial 
weakness do not occur unless there is displacement and compression of the medulla 
against the clivus. There is often paresis of conjugate lateral gaze to the side of the 
hemorrhage, forced deviation of the eyes to the opposite side, or an ipsilateral sixth 
nerve weakness. Vertical eye movements are retained. Other ocular signs include 
blepharospasm, involuntary closure of one eye, skew deviation, â€œocular bobbing, 
and small, often unequal pupils that continue to react until very late in the illness. 
Occasionally, at the onset, there is a spastic paraparesis or a quadriparesis with 
preservation of consciousness. The plantar reflexes are flexor in the early stages but 
extensor later. When these signs occur, hydrocephalus is present and may require 
drainage. In the series of St. Louis et al, those with vermian clots and hydrocephalus 
were at the highest risk for deterioration. As the hours pass, and occasionally with 
unanticipated suddenness, the patient becomes stuporous and then comatose or 
suddenly apneic as a result of brainstem compression, at which point reversal of the 
syndrome, even by surgical therapy, is seldom successful. 
Lobar Haemorrhage 
 Bleeding in areas other than those listed above, specifically in the subcortical 
white matter of one of the lobes of hemisphere, is not associated strictly with 
hypertension; it is presented here for ease of exposition. Any number of other causes 
are usually responsible, the main ones being anticoagulation or thrombolytic therapy, 
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arteriovenous malformation (discussed further on), trauma, and, in the elderly, 
amyloidosis of the cerebral vessels. 
Laboratory Findings 
Among laboratory methods for the diagnosis of intracerebral hemorrhage, the CT 
scan occupies the foremost position. This procedure has proved totally reliable in the 
detection of hemorrhages that are 1.0 cm or more in diameter. Smaller pontine 
hemorrhages are visualized with less certainty. At the same time, coexisting 
hydrocephalus, tumor, cerebral swelling, and displacement of the intracranial 
contents are readily appreciated. MRI is particularly useful for demonstrating 
brainstem hemorrhages and residual hemorrhages, which remain visible long after 
they can no longer be seen by the CT scan (after 4 to 5 weeks). Haemosiderin and 
iron pigment have their own characteristic appearances, as described earlier. 
In general, lumbar puncture is ill advised, for it may precipitate or aggravate an 
impending shift of central structures and herniation. The white cell count in the 
peripheral blood may rise transiently to 15,000/mm
3
, a higher figure than in 
thrombosis. The sedimentation rate is mildly elevated in some patients. 
Course and Prognosis 
The immediate prognosis for large and medium-sized cerebral clots is grave; some 
30 to 35 percent of patients die in 1 to 30 days. Either the hemorrhage extends into 
the ventricular system or intracranial pressure is elevated to levels that preclude 
normal perfusion of the brain. Sometimes the hemorrhage itself seeps into vital 
centers such as the hypothalamus or midbrain. A formula that predicts outcome of 
hemorrhage based on clot size has been devised by Broderick and coworkers; it is 
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mainly applicable to putaminal and thalamic hemorrhages. They found a close 
correlation with outcome. A volume of 30 mL or less, calculated from the CT scan, 
predicted a generally favorable outcome; only 1 of their 71 patients with clots larger 
than 30 mL had regained independent function by 1 month. By contrast, in patients 
with clots of 60 mL or larger and an initial Glasgow Coma Scale score of 8 or less, 
the mortality was 90 percent (this scale is detailed on page 754). As remarked earlier, 
it is the location of the hematoma, not simply its size, that determines the clinical 
effects. A clot 60 mL in volume is almost uniformly fatal if situated in the basal 
ganglia but may be more benign if located in the frontal or occipital lobe. From the 
studies of Diringer and colleagues, it appears that hydrocephalus is also an important 
predictor of poor outcome, and this accords with our experience. 
In patients who survived., in those with smaller hemorrhages, there can be a 
surprising degree of restoration of function, since, in contrast to infarction, the 
hemorrhage has to some extent pushed brain tissue aside rather than destroyed it. 
Function may return very slowly, however, because extravasated blood takes time to 
be removed from the tissues. Also, since rebleeding from the same site is unlikely, 
the patient may live for many years. In some instances of medium-sized cerebral and 
cerebellar hemorrhages, papilledema appears after several days of increased 
intracranial pressure. This does not mean that the hemorrhage is increasing in size or 
swelling only that papilledema is slow to develop. Healed scars impinging on the 
cortex are liable to be epileptogenic; the frequency of seizures after each type of 
hemorrhage has not been established, but it is lower than for ischemic strokes. There 
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is probably no need to administer anticonvulsive medication unless a seizure has 
occurred. 
The poor prognosis of all but the smallest pontine hemorrhages has already been 
mentioned. Cerebellar hemorrhages present special problems that are discussed 
below. 
Associated Systemic Changes 
 Acute subarachnoid hemorrhage is associated with several characteristic 
responses in the systemic circulation, water balance, and cardiac function. The ECG 
changes include symmetrically large peaked T waves and other alterations 
suggesting subendocardial or myocardial ischemia. Also there is a tendency to 
develop hyponatremia; this abnormality and its relationship to intravascular volume 
depletion plays a key role in treatment, as discussed further on. Albuminuria and 
glycosuria may be present for a few days. Rarely, diabetes insipidus occurs in the 
acute stages, but water retention or a natriuresis is more frequent. There may be a 
leukocytosis of 15,000 to 18,000 cells per cubic millimeter, but the sedimentation 
rate is usually normal. 
Course and Prognosis 
 The outstanding characteristic of this condition, mentioned earlier, is the 
tendency for the hemorrhage to recur from the same site. This threat colors all 
prognostications and dominates modern treatment strategies. Unfortunately there 
appears to be no way of determining reliably which patients will bleed again. The 
cause of recurrent bleeding is not understood but may be related to naturally 
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occurring mechanisms of clot formation and lysis at the site of initial rupture, usually 
at the dome of the aneurysm. 
 Patients with the typical clinical picture of spontaneous subarachnoid 
hemorrhage in whom an aneurysm or arteriovenous malformation cannot be 
demonstrated angiographically have a distinctly better prognosis than those in whom 
the lesion is visualized (Nishioka et al). In a series of 323 angiographically negative 
cases followed for an average of 10 years, there was rebleeding in only 12 (Hawkins 
et al). After 22 years, 69 percent of these patients had survived. It is customary in 
most centers to repeat the arteriogram in several weeks, because it has been observed 
that vascular spasm may have earlier obscured the aneurysm. It is advantageous to 
obtain x-rays from several different angles in order to expose those views that were 
obscured by adjacent overlying vessels. If the first study involves all cerebral vessels 
and utilizes several views of the basal circulation, it has been our experience that the 
second arteriogram is infrequently more revealing but our practice is to repeat it 
nonetheless. 
 Another clinical circumstance with a favorable outcome is limited 
perimesencephalic hemorrhage, described by van Gijn and colleagues. The cisterns 
surrounding the midbrain and upper pons are symmetrically filled with blood, the 
headache is mild, and signs of vasospasm do not develop. No aneurysm is found at 
the expected site for blood in this region, i.e., at the top of the basilar artery. The 
patient usually does well and a second arteriogram is probably not required. It has 
been speculated that the bleeding has a venous rather than an aneurysmal source. 
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As regards prognosis of aneurysmal hemorrhage, McKissock and colleagues decades 
ago found that the patient's state of consciousness at the time of arteriography was 
the single best index of outcome, and this remains true today. Their data, 
representative of the status of aneurysm management in the 1950s and consonant 
with the natural history before the advent of modern surgical and intensive care 
techniques, indicated that of every 100 patients reaching a hospital and coming to 
arteriography, 17 were stuporous or comatose and 83 appeared to be recovering from 
the ictus. At the end of the following 6 months, 8 of every 100 patients had died of 
the original hemorrhage and 59 had had a recurrence (with 40 deaths), making a total 
of 48 deaths and 52 survivors. In regard to recurrence of bleeding, it was found that 
of 50 patients seen on the first day of the illness, 5 rebled in the first week (all fatal), 
8 in the second week (5 fatal), 6 in the third and fourth weeks (4 fatal), and 2 in the 
next 4 weeks (2 fatal), making a total of 21 recurrences (16 fatal) in 8 weeks. 
The most comprehensive long-term analysis of the natural history of the disease is 
contained in the report of the Cooperative Study of Intracranial Aneurysms and 
Subarachnoid Haemorrhage (Sahs et al). This study was based on long-term 
observations of 568 patients who sustained an aneurysmal bleed between 1958 and 
1965 and were managed only by a conservative medical program. A follow-up 
search in 1981 and 1982 disclosed that 378, or two-thirds of the patients, had died; 
40 percent of the deaths had occurred within 6 months of the original hemorrhage. 
For the patients who survived the original hemorrhage for 6 months, the chances of 
survival during the next two decades were significantly worse than those of a 
matched normal population. Rebleeding occurred at a rate of 2.2 percent per year 
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during the first decade and 0.86 percent per year during the second. Rebleeding 
episodes were fatal in 78 percent of cases. These statistics, however, also reflect the 
outcome prior to the modern era of microsurgery and neurologic intensive care 
management. 
One would expect these figures to have improved in recent years, but the change has 
not been striking. In a prospective clinical trial conducted by the International 
Cooperative Study in 1990 and based on observations of 3521 patients (surgery 
performed in 83 percent), it was found, at the 6-month evaluation, that 26 percent of 
the patients had died and 58 percent had made a good recovery (Kassell et al). 
Vasospasm and rebleeding were the leading causes of morbidity and mortality in 
those who survived the initial bleed. 
 In respect to rebleeding, all series indicate that the risk is greatest in the first 
day but extends for weeks. The observations of Aoyagi and Hayakawa are similar to 
those of other series; they found that rebleeding occurred within 2 weeks in 20 
percent of patients, with a peak incidence in the 24 h after the initial episode. 
Treatment 
This is influenced by the neurologic and general medical state of the patient as well 
as by the location and morphology of the aneurysm. Ideally, all patients should have 
the aneurysmal sac obliterated, but the mortality is high if the patient is stuporous or 
comatose (grade IV or V, see below). Before deciding on a course of action, it has 
been useful to assess the patient with reference to the widely Eployed scale 
introduced by Botterell and refined by Hunt and Hess, as follows: 
Grade I. Asymptomatic or with slight headache and stiff neck 
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Grade II. Moderate to severe headache and nuchal rigidity but no focal or lateralizing 
neurologic signs 
Grade III. Drowsiness, confusion, and mild focal deficit 
Grade IV. Persistent stupor or semicoma, early decerebrate rigidity and vegetative 
disturbances 
Grade V. Deep coma and decerebrate rigidity 
The general medical management in the acute stage includes the following, all or in 
part: bed rest, fluid administration to maintain above-normal circulating blood 
volume and central venous pressure, use of elastic stockings and stool softeners; 
administration of beta blockers, calcium channel blockers, intravenous nitroprusside, 
or other medication to reduce greatly elevated blood pressure and then maintain 
systolic blood pressure at 150 mmHg or less; and pain-relieving medication for 
headache (this alone will often reduce the hypertension). The prevention of systemic 
venous thrombosis is critical, usually accomplished by the use of cyclically inflated 
whole-leg compression boots. The use of anticonvulsants is controversial; many 
neurosurgeons administer them early, with a view of preventing a seizure-induced 
risk of rebleeding. We have generally avoided them unless a seizure has occurred. 
Calcium channel blockers are being used extensively to reduce the incidence of 
stroke from vasospasm. Nimodipine 60 mg, administered orally every 4 h, is 
currently favored. Although calcium channel blockers do not alter the incidence of 
angiographically demonstrated vasospasm, they have reduced the number of strokes 
in each of five randomized studies, beginning with the one conducted by Allen and 
colleagues. Several groups have been using angioplasty techniques to dilate 
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vasospastic vessels and reporting symptomatic improvement, but there are as yet 
insufficient controlled data to judge the merits and safety of this procedure. 
The most notable advances have been in the techniques for the obliteration of 
aneurysms, particularly the operating microscope and endovascular approaches, and 
in the management of circulatory volume. In the majority of patients intravascular 
volume is depleted in the days after subarachnoid hemorrhage. This, in turn, greatly 
increases the chances of ischemic infarction from vasospasm, though it does not alter 
its incidence or severity. In part, this volume contraction can be attributed to bed 
rest, but sodium loss, probably resulting from the release of atrial natriuretic factor 
(ANF), a potent oligopeptide stimulator of sodium loss in renal tubules, may also be 
a factor. Hyponatremia develops in the first week after hemorrhage, but it is unclear 
whether this also results from the natriuretic effects of ANF or is an effect of 
antidiuretic hormone, causing water retention. The work of Diringer and co-workers 
suggests that both mechanisms are operative, but we would emphasize that it is the 
volume depletion, not hyponatremia per se, that is of the greatest clinical 
consequence. 
 Both the risk of re-rupture of the aneurysm and some of the secondary 
problems that arise because of the massive amount of blood in the subarachnoid 
space can be obviated by early obliteration of the aneurysm. Because of the changes 
in water balance and the risk of delayed stroke from vasospasm, there has been an 
emphasis on early volume expansion and sodium repletion by the intravenous 
infusion of crystalloids. As Solomon and Fink have pointed out, this can be 
accomplished with relative safety and without fear of aneurysmal rupture if blood 
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pressure is allowed to rise only minimally. And, or course, fluid replacement and a 
modest elevation of blood pressure become completely safe if the aneurysm has been 
surgically occluded. Thus the current approach is to operate early, within 36 h if 
possible, on all patients in grades I and II and then to increase intravascular volume 
and maintain normal or above-normal blood pressures. This eliminates the risk of re-
bleeding, with its high mortality, and helps prevent the second cause of morbidity, 
stroke from vasospasm. The timing of surgery or endovascular treatment for grade 
III patients is still controversial, but if their medical condition allows, they too 
probably benefit from the same early and aggressive approach. In grade IV patients, 
the outcome is generally dismal, no matter what course is taken, but we have usually 
counselled against early operation; some neurosurgeons disagree. The insertion of 
ventricular drains into both frontal horns has occasionally raised a patient with 
severe hydrocephalus to a better grade and facilitated early operation. In the  
hands of experienced anesthesiologists and cerebrovascular surgeons, the operative 
mortality, even in grade III and IV patients, has now been reduced to 2 to 3 percent. 
For a detailed account of the operative approach to each of the major classes of 
saccular aneurysm, the reader is referred to the monograph by Ojemann and 
colleagues. 
Several alternative therapeutic measures are still being studied. Among these, 
endovascular obliteration of the lumen of the aneurysm holds the most promise. This 
has become the preferred approach for aneurysms that are surgically inaccessible for 
example, those in the cavernous sinus or for patients whose medical state precludes 
an operation. Among several trials that have compared surgery with endovascular 
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placement of coils in the aneurysm, several have shown a slight superiority of the 
latter. For example, the International Subarachnoid Aneurysm Trial Group randomly 
assigned over 2000 patients to surgery or platinum coil placement; the overall rate of 
death or dependence at 1 year was 24 percent in the endovascular group and 31 
percent in the operated group. Doubtless, further studies will continue to clarify the 
relative benefits of the treatment. We would comment that the skill of the surgeon 
and the quality of postoperative care are major determinants of outcome; perhaps the 
simplicity of endovascular treatment and the improvements in the training of 
interventional specialists will prove its advantage over time. 
Because of the current approach of ablating the aneurysm early, the previously 
popular use of antifibrinolytic agents as a means of impeding lysis of the clot at the 
site of aneurysmal rupture has been generally abandoned. Repeated drainage of the 
CSF by lumbar puncture is also no longer practiced as a routine. One lumbar 
puncture is generally carried out for diagnostic purposes if the CT scan is 
inconclusive; thereafter spinal fluid drainage is performed only for the relief of 
intractable headache or to detect recurrence of bleeding. As mentioned earlier, 
patients with stupor or coma who have massive hydrocephalus often benefit from 
decompression of the ventricular system. This is accomplished initially by external 
drainage and may require permanent shunting if the hydrocephalus returns. The risk 
of infection of the external shunt tubing is high if it is left in place for much more 
than 3 days. Replacement with a new tube, preferably at another site, reduces this 
risk. 
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Unruptured Intracranial Aneurysms 
Not infrequently, cerebral angiography, MRI, MRA, or CT scanning performed for 
an unrelated reason, discloses the presence of an unruptured saccular aneurysm. Or, 
a second or third aneurysm is found during the angiogram to assess a ruptured one. 
There is now a reasonable body of information about the natural history of these 
lesions. Wiebers and colleagues observed 65 patients with one or more unruptured 
aneurysms for at least 5 years after their detection. The only clinical feature of 
significance relative to rupture was aneurysmal size. None of 44 aneurysms smaller 
than 10 mm in diameter had ruptured, whereas 8 of 29 aneurysms 1 cm or larger 
eventually did so, with a fatal outcome in 7 cases. Two large studies have attempted 
to refine these statistical data. In the older Cooperative Study of Intracranial 
Aneurysms, none of the aneurysms less than 7 mm diameter had further trouble. A 
more recent and quite sizable cooperative study that included 4060 patients and 
gathered data prospectively for 5 years, conducted by the International Study of 
Unruptured Intracranial Aneurysms Investigators, found an extremely low rate of 
rupture, about 0.1 percent yearly, for aneurysms smaller than 7 mm in diameter, an 
annual risk of 0.5 percent was found for aneurysms between 7 and 10 mm, and a risk 
ranging from 0.6 to 3.5 percent for lesions between 13 and 24 mm (depending on 
location). The risk ranged up to 10 percent for aneurysms greater than 25 mm 
diameter. The yearly rates for rupture were higher in all categories if there had been 
prior bleeding from another site. The location of the lesion also had great bearing on 
the risk of rupture, as did increasing age; notably, vertebrobasilar and posterior 
cerebral aneurysms bled at a rate many times higher than the others. The importance 
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of such data is underscored by the comparison to the risk of surgery and 
endovascular treatment, which begin to exceed the risk of bleeding within 5 years in 
the smaller aneurysms located in the carotid circulation. 
Giant Aneurysms 
As has been stated, these are believed to be congenital anomalies even when there is 
considerable atherosclerosis in their walls. They may become enormous in size, by 
definition greater than 2.5 cm in diameter, but sometimes twice or more as large. 
Most are located on a carotid, basilar, anterior, or middle cerebral artery. They grow 
slowly by accretion of blood clot within their lumens or by the organization of 
surface blood clots from small leaks. At a certain point they may compress adjacent 
structures, e.g., those in the cavernous sinus, optic nerve, or lower cranial nerves. 
The giant fusiform aneurysm of the midbasilar artery, with signs of brainstem 
ischemia and lower cranial nerve palsies, is a relatively common form. Clotting 
within the aneurysm may cause ischemic infarction in its territory of supply. Giant 
aneurysms may rupture and cause subarachnoid hemorrhage, but not nearly as often 
as saccular aneurysms. This clinical observation has been confirmed by the 
International Study, referred to above. 
Treatment is surgical if the lesion is symptomatic and it is accessible; treatment is 
with endovascular techniques if the lesion is in the vertebral or midbasilar artery. 
Obliteration of the lumen, coupled with vascular bypass procedures, has been 
successful in the hands of a few cerebrovascular neurosurgeons, but the morbidity is 
high. Some aneurysms can be ligated at their necks, others by trapping or by the use 
of an intravascular detachable balloon. Drake has summarized his experience in the 
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treatment of 174 such cases. Ojemann and colleagues have also had singular success 
in treating these lesions by a combination of surgical techniques; in more than 40 
cases, half of them trapped and half obliterated, there was not a single fatality. Some 
have been wrapped in muslin or similar material with mixed results. We have 
followed one such patient operated by T. Sundt over 25 years ago. Recent attempts at 
stabilizing the expansion of the aneurysm by stenting are under study. 
Arteriovenous Malformations of the Brain 
An arteriovenous malformation (AVM) consists of a tangle of dilated vessels that 
form an abnormal communication between the arterial and venous systems, really an 
arteriovenous fistula. It is a developmental abnormality representing persistence of 
an embryonic pattern of blood vessels and is not a neoplasm, but the constituent 
vessels may proliferate and enlarge with the passage of time. Arteriovenous 
malformations have been designated by a number of other terms, such as angioma 
and arteriovenous aneurysm, but these are less appropriate; angioma suggests a 
tumor, and the term aneurysm is generally reserved for the lesions described in the 
preceding section. Venous malformations, consisting purely of distended veins deep 
in the white matter, are a separate entity; they may be the cause of seizures and 
headaches but seldom of hemorrhage. When a small hemorrhage occurs in relation to 
venous malformation, it is usually due to an associated cavernous malformation. 
Vascular malformations vary in size from a small blemish a few millimeters in 
diameter lying in the cortex or white matter to a huge mass of tortuous channels 
constituting an AV shunt of sufficient magnitude, in rare instances, to raise cardiac 
output. Hypertrophic dilated arterial feeders can be seen approaching the main lesion 
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and to break up into a network of thin-walled blood vessels that connect directly with 
draining veins. The latter often form greatly dilated, pulsating channels, carrying 
away arterial blood. The tangled blood vessels interposed between arteries and veins 
are abnormally thin and do not have the structure of normal arteries or veins. 
Arteriovenous malformations occur in all parts of the cerebrum, brainstem, and 
cerebellum (and spinal cord), but the larger ones are more frequently found in the 
central part of a cerebral hemisphere, commonly forming a wedge-shaped lesion 
extending from the cortex to the ventricle. Some lie on the dural surface of the brain 
or spinal cord, but these most often turn out to be direct arteriovenous fistulas, as 
discussed further on. 
When hemorrhage occurs, blood may enter the subarachnoid space, producing a 
picture almost identical to that of ruptured saccular aneurysm, but generally less 
severe; since most AVMs lie within cerebral tissue, bleeding is more than likely to 
be intracerebral as well, causing a hemiparesis, hemiplegia, and so forth, or even 
death. 
Arteriovenous malformations are about one-tenth as common as saccular aneurysms 
and about equally frequent in males and females. The two lesions AVM and saccular 
aneurysm (on the main feeding artery of the AVM)are associated in about 5 percent 
of cases; the conjunction increases with the size of the AVM and the age of the 
patient (Miyasaka et al). Rarely, AVMs occur in more than one member of a family 
in the same generation or successive ones. 
For a review of the Embryologic theories of formation of AVMs, the reader is 
directed to the article by Fleetwood and Steinberg. 
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Clinical Features 
Bleeding or seizures are the main modes of presentation. Most AVMs are clinically 
silent for a long time, but sooner or later they bleed. The first hemorrhage may be 
fatal, but in more than 90 percent of cases the bleeding stops and the patient 
survives. The rate of hemorrhage in untreated patients is established to be 2 to 4 
percent per year, far lower than for aneurysms. The mortality rate in two major series 
(Crawford et al, Ondra et al) has been 1 to 2 percent per year but as high as 6 to 9 
percent in the immediate year following a first hemorrhage. The matter of an 
increased risk of AVM rupture during pregnancy has been disputed. The weight of 
evidence suggests that the risk is not raised by pregnancy alone, but as with saccular 
aneurysm that parturition and Valsalva activity is always a source of concern. Before 
rupture, chronic, recurrent headache may be a complaint; usually the headache is of a 
nondescript type, but a classic migraine with or without neurologic accompaniment 
occurs in about 10 percent of patients probably with greater frequency than it does in 
the general population. Most of the lesions associated with migraine-like headaches 
lie in the parieto-occipital region of one cerebral hemisphere, and about two-thirds of 
such patients have a family history of migraine. 
Huge AVMs may produce a slowly progressive neurologic deficit because of 
compression of neighbouring structures by the enlarging mass of vessels and by 
shunting of blood through greatly dilated vascular channels intracerebral steal), 
resulting in hypoperfusion of the surrounding brain (Homan et al). When the vein of 
Galen is enlarged as a result of drainage from an adjacent AVM, hydrocephalus may 
result. Not infrequently one or both carotid arteries pulsate unusually forcefully in 
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the neck. A systolic bruit heard over the carotid in the neck or over the mastoid 
process or the eyeballs in a young adult is almost pathognomonic of an AVM. 
However, such bruits have been heard in fewer than 25 percent of our patients. 
Exercise that increases the pulse pressure may bring out a bruit if none is present at 
rest. 
The blood pressure may be elevated or normal; it is axiomatic that the occurrence of 
intracranial bleeding with a previously normal blood pressure should raise the 
suspicion of an AVM, but also of ruptured saccular aneurysm, bleeding diathesis, 
cerebral vessel amyloidosis, or hemorrhage into a tumor. Rarely, inspection of the 
eye grounds discloses a retinal vascular malformation that is coextensive with a 
similar lesion of the optic nerve and basal portions of the brain. Cutaneous, orbital, 
and nasopharyngeal AVMs may occasionally be found. Rarely, skull films show 
crescentic linear calcifications in the larger malformations. 
The natural history of AVMs has been studied by Ondra and colleagues, who have 
presented data on a large and comprehensive series of untreated malformations in 
Finland over a 30-year period, and another similar series has been reported by 
Crawford and co-workers in Great Britain. In the latter study, comprising 343 
patients, 217 were managed without surgery and observed for many years (mean, 
10.4 years). Haemorrhage occurred in 42 percent and seizures in 18 percent. By 20 
years after diagnosis, 29 percent had died and 27 percent of the survivors had a 
neurologic handicap. Although the lesion is present from birth, onset of symptoms is 
most common between 10 and 30 years of age; occasionally it is delayed to age 50 or 
even beyond. In almost half of patients, the first clinical manifestation is a cerebral 
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subarachnoid hemorrhage; in 30 percent, a seizure is the first and only manifestation; 
and in 20 percent, the only symptom is headache. Progressive hemiparesis or other 
focal neurologic deficit is present in about 10 percent of patients. In a series of 1000 
patients referred mainly for proton beam radiation of an AVM and studied by our 
colleague R. D. Adams, 464 had a hemorrhage as the first manifestation and 218 had 
a seizure (mainly with frontal and frontoparietal lesions). In 139, the lesion came to 
attention as a result of a progressive neurologic deficit; most of these were situated in 
the posterior fossa or axially in the cerebrum. Headaches were an early symptom in 
212, but only 59 of these patients had a subsequent hemorrhage. The combination of 
a prolonged history of headaches, seizures, and a progressive deficit almost always 
indicated a large malformation. 
Fully 95 percent of AVMs are disclosed by CT scans if enhanced and an even larger 
number by MRI (Fig. 34-25). Magnetic susceptibility MRI shows small areas of 
previous bleeding around AVMs. Arteriography is usually necessary to establish the 
diagnosis with certainty and will demonstrate AVMs larger than 5 mm in diameter 
(Fig. 34-26); MRI may fail to reveal smaller lesions. Small ones may be obscured by 
hemorrhage; even at autopsy, a careful search under the dissecting microscope may 
be necessary to find them. 
Treatment 
The preferred approach in most centers is surgical excision. Some 20 to 40 percent 
of AVMs are amenable to block dissection, with an operative mortality rate of 2 to 5 
percent and a morbidity of 5 to 25 percent (see Fleetwood and Steinberg for a  
76 
 
summary of reported surgical results up to 2002). In the others, which are 
inaccessible, attempts have been made to obliterate the malformed vessels by 
ligation of feeding arteries or by the use of endovascular embolization with liquid 
adhesives or particular material that are injected via a balloon catheter that has been 
navigated into a feeding vessel. Complete obliteration of large AVMs is usually not 
possible by these methods but, they are highly effective in reducing the size of the 
AVM prior to surgery. 
Kjellberg and Chapman pioneered the treatment of AVMs at the Massachusetts 
General Hospital using a single dose of subnecrotizing stereotactically directed 
proton radiation. The technique of radiosurgery has been adopted by others using 
photon radiation sources, such as a linear accelerator, gamma knife, and other modes 
of focused x-ray radiation, as an accepted alternative to operative treatment of 
lesions situated in deep regions, including the brainstem, or in eloquent areas of the 
cortex. Generally, malformations smaller than 3 cm diameter are treatable in this 
way. Radiosurgical obliteration of AVMs occurs in a delayed manner, usually with a 
latency of at least 18 to 24 months after treatment. During this early period the 
patient is unprotected from rebleeding. 
 The likelihood of successful treatment and the nature of the risks depend on 
the location and size of the AVM and the radiation dose delivered. After 2 years, 75 
to 80 percent of AVMs smaller than 2.5 cm in diameter have been obliterated. Even 
for those AVMs that have not been totally eliminated, the radiation effect appears to 
confer some long-term protection from bleeding. Of the larger ones, a majority are 
shrunken or appear less dense. The rest have shown no change at this low dose level, 
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but even in this group, the morbidity and mortality are lower than in the untreated 
group. However, a proportion of larger AVMs that are obliterated will recanalize, 
and many of these will subsequently bleed. Among more than 250 patients whose 
AVMs disappeared following proton beam therapy, there has been no recurrence of 
hemorrhage for up to 10 years; in larger AVMs (approximately the last 1000  
cases) treated in this way, the frequency and severity of hemorrhage have been 
significantly reduced. The results of treatment with focused gamma radiation have 
been about the same. In one study, the risk of hemorrhage was reduced by 54 percent 
between the time of radiation and obliteration of the malformation and by 88 percent 
thereafter (Maruyama et al). 
Two types of complications of radiation occur at a combined rate of approximately 2 
to 4 percent. The first is delayed radiation necrosis, which is predictable based on the 
radiation dose, and the second is a venous congestion that occurs several weeks or 
months after treatment. The latter is indicative of the desired effect of thrombosis of 
the malformation. Both cause local symptoms for weeks or months. Radiation 
necrosis may be reduced by the administration of corticosteroids but the vascular 
problem generally is not helped. 
 The treatment of AVMs by endovascular techniques is increasingly popular 
but has not been fully evaluated. Nearly every AVM has several feeding arteries, 
some not reachable by catheter, and some part of the AVM remains after treatment. 
In most series, 25 percent or more of AVMs, mostly of small and medium size, could 
be completely obliterated, with a mortality rate below 3 percent and morbidity of 5 
to 7 percent, which compares favorably with surgical outcomes. These techniques 
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are also particularly well adapted to lesions of a combined AVM and an aneurysm on 
the feeding vessel. 
 Most recently, combined therapy that begins with endovascular reduction of 
the lesion and is followed by either surgery or radiation has been viewed most 
favorably. In series of patients using this approach, over 90 percent of lesions could 
be obliterated with a very low rebleeding rate over several years. What is clear is that 
the plan for each patient must be individualized based on the size, location, nature of 
feeding vessels, the presence of other vascular lesions (aneurysm or additional 
AVM), and the age of the patient. Even then, there will be differences of opinion 
based on local resources and experience. 
Finally, if the primary problem is recurrent seizure, successful treatment with 
reduction or cessation of seizures is achieved in a very high proportion of cases. The 
results are comparable to those from surgery and radiation, even if the AVM is not 
entirely obliterated. 
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MATERIALS AND METHODS: 
 STUDY POPULATION: 
 This study is to be conducted among 60 patients who are admitted with an 
acute onset of neurological deficit in the Department of Medicine in Government 
Rajaji Hospital, Madurai. 
Inclusion criteria: 
 Patients whose deficit lasted for more than 24 hours 
 CT scan showed cerebral infarction or intra-cerebral hemorrhage 
 Patients of  both sex 
 Patients age > 18 years 
Exclusion criteria: 
 Age <18 years 
 Duration of stroke  > 14 days because of the possibility of missing an ICH 
 Causes of focal neurological deficit other than stroke (tuberculosis, tumor or 
trauma , transient ischemic attack) 
 Patients on anti-coagulation therapy 
 Patients in whom CT scan could not be done 
 Patients admitted 72 hours after the onset of neurological deficit 
 Patients with sub-arachnoid hemorrhage 
 Repeat or recurrent stroke 
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ANTICIPATED OUTCOME: 
  Based on clinical variables such as level of consciousness , blood pressure, 
atheroma markers and the presence of headache, vomiting,  Siriraj Stroke Score, a 
clinical scoring is to be used for the bedside diagnosis of the nature of the lesion in 
stroke patients where CT scan is not available. 
DATA COLLECTION: 
On admission, detailed history and thorough clinical examination including 
neurological assessment will be carried out. Patient’s level of consciousness will be 
assessed by Glasgow Coma Scale (GCS). 
RADIOLOGICAL  INVESTIGATION: 
Computed Tomography (CT)  Brain 
STUDY PROTOCOL: 
On admission detailed history and thorough clinical examination including 
neurological assessment will be carried out. Patients will be assumed to be fully 
conscious if they had a score of >13 on the Glasgow Coma Scale (GCS), drowsy if 
they had a GCS score of 8–13 and unconscious if they scored <7 . Siriraj Stroke 
Score will be calculated and compared with the CT findings done on admission. A 
radiologist from the hospital, blind to the clinical features, will classify the CT brain 
scans as either infarction or haemorrhage.  
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Siriraj Stroke Score (SSS) will be calculated using the formula = (2.5×level of 
consciousness) + (2×vomiting) + (2×headache) + (0.1×diastolic blood pressure) - 
(3×atheroma markers) -12.  
 This will be computed for each patient. Scores will be calculated by obtaining 
details of each clinical variable. If any variable is not available e.g. if patient is 
unconscious, information will be obtained from patient’s relatives. If the relatives 
were unaware of a particular variable, then the variable score will be adjusted as 
zero. A score above 1 indicates intracranial haemorrhage, while a score below -1 
indicates infarction. The score between 1 and -1 represents an equivocal result. 
DESIGN OF STUDY: Cross Sectional Study 
PERIOD OF STUDY: MARCH 2016 TO AUGUST 2016 
COLLABORATING DEPARTMENTS: 
Department of General Medicine  
Department of Radiology 
ETHICAL CLEARANCE: Obtained 
CONSENT: Individual written and informed consent. 
ANALYSIS:  Statistical analysis 
CONFLICT OF INTEREST : Nil 
FINANCIAL SUPPORT:  Nil 
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PARTICIPANTS:  Patients admitted with an acute onset of neurological deficit at 
Department of Medicine, Government  Rajaji  Hospital,  Madurai will be enrolled  
and who satisfy the inclusion and exclusion criteria.                                            
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RESULTS   AND   INTERPRETATIONS 
Table - 1 
Age distribution 
Age No of Patients % 
<50 10 16.67 
51-60 21 35.00 
61-70 15 25.00 
>70 14 23.33 
Total 60 100.00 
Mean 60.03   
SD 10.63   
 
AGE DISTRIBUTION
10
21
15
14
0
5
10
15
20
25
<50 51-60 61-70 >70
No Of Patients
 
Most of the patients were in the age between 50 to 60 years though it ranged from 40 to 
80 years old. Out of 60 patients, 21 of them were in the age group of 50 to 60 years. 
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Table – 2 
Sex No of Patients % 
Male 39 65.00 
Female 21 35.00 
Total 60 100.00 
 
 
 
                                                    Of the total patients, 65 % were male 
 
 
SEX DISTRIBUTION 
 65% 
35% 
Male Female 
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TABLE - 3 
Level of 
Consciousness 
No of Patients 
% 
SCORE 0 9 15.00 
SCORE 1 46 76.67 
SCORE 2 5 8.33 
Total 60 100.00 
 
9
46
5
0
10
20
30
40
50
SCORE 0 SCORE 1 SCORE 2
CONSCIOUSNESS
No Of Patients
 
Score 0 denotes unconscious, score 1 denotes drowsy, score 2 denotes conscious. 
Level of consciousness was assessed by Glasgow coma scale (GCS). 46 out of the 
total 60 were admitted in drowsy state. 
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Table – 4 
Vomiting 
Vomiting No Of Patients % 
Present (P) 11 18.33 
Absent (A) 49 81.67 
Total 60 100  
 
49
11
0
10
20
30
40
50
A P
VOMITING
A P
 
Out of total 60 patients only 11 patients had vomiting within 24 hours  
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Table – 5 
Headache within 4 hours 
Headache within 2 hrs No Of Patients % 
Absent(A) 54 90.00 
Present(B) 6 10.00 
Total 60 100.00 
 
 
Headache was present in 6 patients out of total 60 cases within 4 hours 
 
 
54 
6 
0 
10 
20 
30 
40 
50 
60 
A P 
HEADACHE WITHIN 4 HOURS 
A P 
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Table – 5 
Diastolic BP 
Diastolic 
BP(mm Hg) 
No Of 
Patients % 
<150 15 25.00 
>150 45 75.00 
Total 60 100.00 
 
                     
DIASTOLIC BP
15
45
<150 >150
 
45 patients out of total 60 had diastolic BP >150 mm Hg 
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Table - 6 
Atheroma 
markers 
No Of Patients 
% 
SCORE 0 20 33.33 
SCORE 1 40 66.66 
Total 60 100.00 
 
Atheroma markers (diabetes, angina, intermittent claudication) were present in 40 
out of total 60 patients. 
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Table - 7 
Siriraj stroke score NO.OF CASES % 
<-1 31 51.67 
  -1  to  +1     11 18.33 
>+1 18 30.00 
Total 60 100.00 
 
P value - 0.015  Significant 
 
 
< - 1 denotes infraction, > +1 denotes hemorrhage, -1 to +1 denotes equivocal 
By Siriraj score 31 out of the 60 patients had infarction and only 18 patients had 
hemorrhage, 11 patients showed equivocal score.   
31 
11 
18 
0 
5 
10 
15 
20 
25 
30 
35 
<-1   -1  to  +1     >1 
SIRIRAJ STROKE SCORE 
<1   -1  to  +1     >1 
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Table – 8 
Siriraj Stroke Score and CT comparison 
Siriraj stroke 
score 
Infarction Hemorrhage Total 
< -1 25 6 31 
-1 to + +1 8 3 11 
> +1 12 6 18 
Total 45 15 60 
 
Comparing CT scan, 25 out of the 45 patients had infarction and 6 out of 18 patients 
had hemorrhage. Out of 11 equivocal score 8 patients had infarction and three 
patients had hemorrhage 
25 
6 
8 
3 
12 
6 
0 
5 
10 
15 
20 
25 
< -1   -1  to  +1     > +1 
SIRIRAJ STROKE SCORE VS CT COMPARISON 
Infarction Haemorrhage 
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Table – 9 
 
Comparison of Siriraj Stroke Score (SSS) with CT Brain Scan 
 
Diagnosis of Ischemic Stroke 
 
Siriraj stroke 
score 
Infarction Non – infarction Total 
<-1 25 6 31 
>+1 and 
 -1 to +1 
20 9 29 
total 45 15 60 
 
Sensitivity           -            55.55% 
Specificity                        - 60% 
Positive predict value -    80.64 % 
Negative predict value – 31.03 % 
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25
6
20
9
0
5
10
15
20
25
  < -1     > +1  and  -1  to  +1
Siriraj Stroke Score with  CT Brain scan Diagnosis of Ischemic stroke
Infarction Non – infarction
 
By score 25 patients showed infarction out of the total 31 cases 
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Table - 10           
 
Comparison of Siriraj Stroke Score (SSS) with CT Brain Scan 
 
Diagnosis of Hemorrhagic Stroke 
 
Siriraj stroke 
score 
Hemorrhage Non Hemorrhage Total 
> +1 6 12 18 
< -1 and  
-1 to +1 
9 33 42 
Total 15 45 60 
 
  Sensitivity  - 40% 
  Specificity  - 73% 
  Positive predict value- 33.33 % 
  Negative predict value - 78.57 % 
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6
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> +1  < -1  and  -1  to  +1
Siriraj Score with CT Brain scan Diagnosis of Haemorrhagic stroke
Haemorrhage Non-Haemorrhage
 
Out of total 18 patients, 6 cases had hemorrhage by score 
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DISCUSSION 
  
 
               We evaluated 60 patients after 24 hours of onset of stroke. On admission, 
detailed history and thorough clinical examination including neurological assessment 
were carried out. Patient’s level of consciousness was assessed by Glasgow Coma 
Scale (GCS). It was assigned fully conscious if they had a score of >13 on the 
Glasgow Coma Scale, drowsy if they had a GCS score of 8–13 and unconscious if 
they scored <7 and we came out with various distributions of parameters as follows 
 
It ranged from 40 to 80 years of age with mean at 60.2 years. 
 
Males exceeded females in all the age group. 
 
Most of the patients had access to reach the hospital within 24 hours though most of 
them could not make it within 3-4 hours of the onset. 
 
The demography coincides with most of other geographical areas and to that found 
in literatures. 
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Level of consciousness as per GCS score was low in the first 24 hours more so in 
haemorrhagic stroke.  
 
Atheroma markers namely diabetes, angina and intermittent claudication were found 
to be more as age increased and in those who had  ischemic stroke. 
  
Vomiting was seen more in haemorrhagic stroke though only few cases of ischemic  
exhibited vomiting, indicating likelihood of vomiting more in haemorrhagic stroke. 
 
 Blood pressure was found to be elevated more in haemorrhagic stroke being 
more in diastolic blood pressure when compared to ischemic stroke as many of 
ischemic stroke also were found to be associated with hypertension but did not 
exceed the 150 mm HG especially for diastolic blood pressure. So, it indicates more 
the blood pressure, haemorrhagic stroke is more likely. 
 
 Headache though a common complaint was found more in cases of 
haemorrhage and ischemic cases exhibited less of it, thus headache is more likely to 
be associated with haemorrhage. 
            In this study, Siriraj score showed positive predictive value of 80.64% for 
ischemic stroke and negative predictive value of 78.57% for hemorrhagic stroke and 
the P value is 0.015 (significant). 
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CONCLUSION 
 
  
Based on clinical variables such as level of consciousness, blood pressure, 
atheroma markers and the presence of headache and vomiting,  Siriraj Stroke 
Score, a clinical scoring can be used for the bedside diagnosis of  the nature of 
the lesion in stroke patients where CT scan is not available immediately.   
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PROFORMA 
 
 
 
Name :        IP No. : 
Sex    :        Department : 
 
General Examinations : 
      Yes   No 
 Vomiting 
 Consciousness 
 Head ache 
 Blood pressure 
 Atheromarkers 
 Score 
CT Report 
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Eq
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1 ANNATHAI 56 M 0 0 0 160 1 1.5 H 
2 RATHINA PAUL 57 M 1 0 0 163 2 1.8 H 
3 RASOOL BEEVI 53 M 1 0 0 150 2 -0.5 I 
4 MUNIAPPAN 54 M 2 0 0 153 2 2.3 H 
5 PANDI 58 F 1 0 0 161 2 1.6 H 
6 EUACHI 51 M 1 0 0 149 2 -0.6 I 
7 KASIPANDI 61 F 1 0 0 159 2 -0.1 I 
8 SUNDAR 57 M 1 0 0 156 2 -0.1 I 
9 LAKSHMI 45 M 1 0 0 163 2 -0.8 I 
10 JEEMNA 75 F 1 0 0 163 2 -0.8 I 
11 
SIVAGURUNATHAN 
53 M 0 1 1 
154 
2 1.4 H 
12 EASWARAN 52 M 1 0 0 147 2 -0.8 I 
13 SUNDARAJAN 61 F 1 0 0 162 2 -0.7 I 
14 SURESH 67 F 1 0 0 157 2 -0.2 I 
15 AYYADURAI 58 M 1 0 0 148 2 -0.7 I 
16 SEKAR 51 M 1 0 0 150 2 -0.5 I 
17 PATTU 53 F 1 0 0 162 2 -0.7 I 
18 THANGARAJ 64 M 1 0 0 158 2 -0.3 I 
19 GURUNATHAN 68 M 1 0 0 161 0 4.4 H 
20 SINGARAJ 76 F 1 0 0 160 2 2.8 I 
21 RAVI 80 F 1 0 0 158 2 6.7 I 
22 ARUNACHALAM 43 F 0 1 1 154 1 -0.4 H 
23 LAKSHMIAMMAL 71 F 0 0 0 148 0 -0.2 H 
24 SHAHUL HAMEED 58 M 1 0 0 162 0 -0.4 H 
25 YOGAMMAL 74 M 1 0 0 159 2 -0.2 I 
26 SELVI 73 M 1 0 0 157 2 -0.2 I 
27 KANAGARAJ 61 F 1 0 0 159 2 -0.4 I 
28 MARIAPPAN 52 M 0 0 0 150 0 3 H 
29 PERIYASAMY 43 F 1 1 1 145 1 6 H 
30 PETCHIMUTHU 72 M 1 0 0 163 2 -0.8 I 
31 ANANDHARAJ 64 M 1 0 0 159 2 -0.4 I 
32 JEYARANI 77 F 0 1 0 160 0 6 H 
33 KALIMUTHU 45 M 1 0 0 164 2 -0.9 I 
34 SANKAR 69 M 1 1 1 155 2 0.7 H 
35 MANDIRAN 55 F 1 0 0 162 2 4.1 I 
36 AMMAPONNU 56 M 1 1 1 156 2 5.3 H 
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37 PARAMASIVAM 73 M 2 0 0 153 1 0 H 
38 KANNAN 70 M 0 1 0 160 2 -0.2 E 
39 MARIAPPAN 43 F 1 0 0 157 2 3 I 
40 MUTHUPETCHI 49 M 0 1 1 140 1 2.2 H 
41 CHANDRAN 52 M 2 0 0 152 2 -0.8 H 
42 RAJAKUMARI 42 M 1 0 0 147 2 1.9 I 
43 KANDAN 72 F 1 1 0 154 2 1 H 
44 MURUGAN 66 M 1 0 0 165 2 0.8 E 
45 CHELLAPPA 54 M 1 0 0 163 2 -0.3 E 
46 PADMAVATHI 65 F 1 0 0 152 2 -0.2 I 
47 MURUGAN 63 M 1 0 0 157 2 1.7 I 
48 NAGESHWARI 53 M 2 1 0 127 2 -0.4 E 
49 MARIAPPAN 68 F 1 0 0 151 2 0.8 E 
50 SIVAKUMAR 47 M 1 0 0 163 2 -0.6 I 
51 MURUGAN 51 M 1 0 0 149 2 0.7 E 
52 PALANIRAJ 46 F 1 0 0 162 2 -2.5 I 
53 VIJAYASHREE 76 M 0 0 0 155 2 0.5 I 
54 CHELLAMMAL 62 M 1 0 0 160 2 2 E 
55 ESWARAN 74 M 2 0 0 150 2 -0.7 E 
56 PATTAMMAL 61 F 1 0 0 162 2 -0.9 I 
57 SENTHIL 44 M 1 0 0 146 2 1.4 I 
58 KANAGAMANI 73 M 1 1 0 149 2 0.3 E 
59 MANIKANDAN 57 M 1 0 0 158 2 0.4 E 
60 SARASWATHI 78 F 1 0 0 159 2 0.4 E 
105 
 
 
 
 
 
106 
 
 
 
107 
 
 
 
 
 
 
 
